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The environment that the oocyte is exposed to during the peri-conception period can 2 
have a significant impact on oocyte developmental competence (the ability of the 3 
oocyte to support fertilisation and subsequent embryo development) and the long-4 
term health of the resulting offspring. This is particularly true for maternal 5 
hyperglycaemia. While maternal hyperglycaemia during early pregnancy and beyond 6 
has been extensively studied, the effects on the oocyte itself, and the underlying 7 
mechanisms, remain largely unknown. However, there is increasing evidence for the 8 
role of the fuel-sensing hexosamine biosynthesis pathway in mediating the effects of 9 
hyperglycaemia in many different cell types. In this review, we will focus on the 10 
reproductive consequences of maternal hyperglycaemia during the peri-conceptual 11 
period and the role of the hexosamine pathway in mediating these processes. 12 
 13 
1. Introduction 14 
Maternal Type I or Type II diabetes, in which blood glucose levels are elevated, have 15 
long been associated with higher risks of a multitude of pregnancy complications, 16 
including spontaneous abortions, neonatal morbidity and mortality and congenital 17 
malformations (Becerra et al. 1990; Cornblath and Schwartz 1976; Farrell et al. 18 
2002; Greene 1999; Norman and Reynolds 2011; Sadler et al. 1988). Many studies 19 
have examined the effect of hyperglycaemia on the early embryo. However, even 20 
when good glycaemic control is achieved during the first few weeks of pregnancy, 21 
there is still a significant risk of pregnancy complications, including fetal 22 
abnormalities, for women with diabetes (Bell et al. 2012; Dunne et al. 1999; Lapolla 23 
et al. 2008b; Ray et al. 2001).  24 
 25 
Studies in animal models (including a significant body of work by Kelle Moley and 26 
her group) have demonstrated that hyperglycaemia may lead to increased fertility 27 
complications even prior to conception. Embryos derived from  diabetic mice are 28 
growth retarded, have higher levels of apoptosis and a decrease in glucose uptake, 29 
and oocytes are smaller, slower to complete meiotic maturation and have altered 30 
mitochondrial distribution compared to those from non-diabetic mice (Chang et al. 31 
2005; Colton et al. 2002; Wang and Moley 2010; Wang et al. 2009). These 32 
observations also extend to the surrounding cumulus and granulosa cells, with a 33 
higher number of apoptotic events observed and a decrease in cumulus cell glucose 34 
uptake (Chang et al. 2005; Dunning et al. 2010). 35 
 36 
One of the primary mechanisms  by which somatic cells are negatively affected by 37 
hyperglycaemia is through increased glucose metabolism through the hexosamine 38 
biosynthetic pathway (HBP) (Brownlee 2001). The HBP is a fuel-sensing pathway, 39 
which converts glucose to UDP-N-acetylglucosamine (UDP-GlcNAc). This moiety 40 
can be attached to serine or threonine residues of proteins and act in an analogous 41 
manner to phosphorylation to regulate protein function; a post-translational 42 
modification called β-O-linked glycosylation (Whelan and Hart 2003). Altered β-O-43 
linked glycosylation is increasingly recognised as being associated with a number of 44 
disease states including cancer, inflammatory conditions and neurodegenerative 45 
diseases (Hart et al. 2007; Yang and Suh 2013). Notably, it is also implicated as a 46 
primary mechanism behind the development of insulin resistance and pancreatic β-47 
cell destruction in type 2 diabetes (Marshall et al. 1991; Yang et al. 2008). 48 
 49 
Pre-ovulatory cumulus-oocyte complexes (COCs) and early embryos exposed to 50 
hyperglycaemic conditions display increased levels of β-O-linked glycosylation and a 51 
subsequent decrease in developmental competence in the mouse, cow and pig 52 
(Pantaleon et al. 2010; Sutton-McDowall et al. 2006). However, the mechanisms 53 
underpinning the adverse effect of excess HBP flux on the developing oocyte and 54 
embryo are unknown.  55 
 56 
This review will briefly describe glucose metabolism in the developing oocyte, the 57 
clinical and biological consequences of hyperglycaemia and the role of the HBP and 58 
β-O-linked glycosylation in reproductive physiology. 59 
  60 
2. The effects of hyperglycaemia on female reproduction 61 
The concentration of glucose in ovarian follicular fluid parallels that of plasma at a 62 
slightly lower level (Gardner and Leese 1990; Leese and Lenton 1990; mouse, 63 
human), and is positively correlated with follicle size (Nandi et al. 2008; Sutton-64 
McDowall et al. 2005; buffalo, sheep, cow). As well as being the defining pathology 65 
of diabetes, elevated blood glucose levels are present in cases of pre-diabetes or 66 
impaired glucose tolerance, where glucose levels are higher than normal but not 67 
high enough for a diagnosis of diabetes (Unwin et al. 2002). Obesity and poor diet 68 
(modelled in mice fed a high fat diet (Jungheim et al. 2010)) are associated with pre-69 
diabetes, impaired glucose tolerance and hyperglycaemia. Importantly, increasing 70 
body mass index is correlated with increasing glucose levels in follicular fluid in 71 
humans (Robker et al. 2009). 72 
 73 
2.1. Clinical consequences of hyperglycaemia on female reproduction 74 
In humans, maternal diabetes is associated with poor conception, difficulty 75 
maintaining pregnancies and delivery of babies with health problems (Becerra et al. 76 
1990; Holing et al. 1998; Jungheim and Moley 2010; Lapolla et al. 2008b; Purcell 77 
and Moley 2011; Rich-Edwards et al. 1994). Women with diabetes have higher risks 78 
of spontaneous first-trimester abortion, preeclampsia, preterm birth and high birth 79 
weight babies (Greene 1999; Hedderson et al. 2003; Middleton et al. 2010; Mills et 80 
al. 1988). Similarly, obese women have increased risks of preeclampsia and 81 
spontaneous abortions (Dokras et al. 2006; Metwally et al. 2008; O'Brien et al. 82 
2003). Consequently, large birth weight babies born to women with diabetes are at 83 
increased risk of developing metabolic syndrome (including insulin resistance) in 84 
childhood (Boney et al. 2005; Silverman et al. 1995).  In rodent models, 85 
streptozotocin-induced diabetes (streptozotocin mediates destruction of the 86 
pancreatic β-cells) during pregnancy results in high birth-weight pups with increased 87 
pancreatic insulin content (Oh et al. 1988). 88 
 89 
Congenital anomalies occur in 6 - 10 % of pregnancies in women with diabetes; 3 - 5 90 
fold higher than the general population (Lapolla et al. 2008a; Reece and Homko 91 
2000). The degree of risk for diabetes-associated complications in pregnancy is 92 
dependent on the level of glycaemic control achieved, with the level of glycosylated 93 
haemoglobin positively correlated with the incidence of fetal malformations (Guerin 94 
et al. 2007; Lapolla et al. 2008b; Miller et al. 1981; Suhonen et al. 2000). The 95 
incidence of fetal anomalies doubles to 5 % with a maternal fasting blood glucose 96 
level of 6.6 mM; below the threshold of a diagnosis of diabetes (7 mM), and further 97 
increases to 30 % with a maternal fasting blood glucose > 14.3 mM (Schaefer et al. 98 
1997). The occurrences of neural tube defects and skeletal and cardiovascular 99 
malformations in particular, are 18 times more common in babies born to mothers 100 
with diabetes (Becerra et al. 1990; Farrell et al. 2002; Greene 1999), or obesity 101 
(Horal et al. 2004; Stothard et al. 2009).  102 
 103 
A hyperglycaemic insult must occur within the first 6 weeks of gestation to produce 104 
an increased likelihood of congenital anomalies, as the increase is not seen in 105 
women with gestational diabetes only (Mills et al. 1979), which is usually diagnosed 106 
around the 24th-28th week of pregnancy (Seshiah et al. 2007). The earlier glycaemic 107 
control can be achieved, the less risk there is of malformations (Miller et al. 1981). 108 
Even so, there is mounting evidence to suggest that even very brief exposure to 109 
hyperglycaemia is enough to cause malformations in the offspring. Wyman et al. 110 
(2008) performed zygote transfers from diabetic to non-diabetic mice, and observed 111 
that despite transferring the embryos to a normoglycaemic environment within 24 112 
hours of fertilisation, embryos derived from donor diabetic mothers developed into 113 
fetuses that were significantly smaller than controls and had increased incidences of 114 
deficient neural tube closure, hydrocephaly and limb defects. Exposure to 115 
hyperglycaemia for 96 hours (to the blastocyst stage) further increased the risk of 116 
resorption or miscarriage.  117 
 118 
The effect of the timing of exposure to hyperglycaemia extends to the pre-conception 119 
period. In human studies, even if optimal glycaemic control is achieved within the 120 
first few weeks of pregnancy, there remains a 3 - 5 times higher risk of spontaneous 121 
abortions and congenital anomalies for babies born to women with diabetes (Baccetti 122 
et al. 2002; Bell et al. 2012; Casson et al. 1997; El-Sayed and Lyell 2001). However, 123 
if a preconception treatment program is undertaken this risk is significantly reduced 124 
(Dunne et al. 1999; Pearson et al. 2007; Ray et al. 2001).  125 
 126 
2.2. Biological consequences of hyperglycaemia: embryos 127 
Abnormally high or low rates of maternal metabolism affect embryo development 128 
(Fleming et al. 2004; Leese et al. 2008). Under hyperglycaemic conditions, glucose 129 
uptake and expression of glucose transporters are reduced in pre-implantation 130 
embryos (Moley 1999; Moley et al. 1998a; Moley et al. 1998b). In a non-obese 131 
diabetic mouse model, significantly fewer embryos reached the blastocyst stage of 132 
development in diabetic mice compared to control mice, and this discrepancy was 133 
reversed by treating the mothers with insulin (Moley et al. 1991). Blastocysts 134 
recovered from diabetic rats had a higher incidence of fragmentation and contained 135 
fewer inner cell mass cells than blastocysts from normoglycaemic mothers (Lea et al. 136 
1996), supporting the notion that a legacy of brief and early exposure to 137 
hyperglycaemia has long term consequences; zygotes removed from diabetic mice 138 
and transferred to non-diabetic surrogates display retarded rates of development to 139 
the two-cell stage in vivo, and embryos recovered after cleavage and cultured in vitro 140 
similarly show a significant delay in their progression to the blastocyst stage 141 
(Diamond et al. 1989). Early embryogenesis alone is susceptible to hyperglycaemic 142 
damage, with mouse embryos treated from the zygote stage in vitro with very high 143 
glucose (27 mM) or glucosamine (0.2 mM), producing fewer blastocysts, with 144 
reduced cell numbers compared to controls, and with increased apoptosis 145 
(Pantaleon et al. 2010). High levels of glucose inhibit the expression in mouse 146 
embryos of Pax-3, a gene required for neural tube closure (Chalepakis et al. 1994). 147 
 148 
2.3. Biological consequences of hyperglycaemia: oocytes 149 
Most diabetic rodent studies focus on pre-implantation embryo development or the 150 
period of foetal organogenesis, around days 9-11 (Wyman et al. 2008). However, 151 
consistent with clinical studies highlighting the benefits of pre-conception care, 152 
hyperglycaemia causes numerous perturbations in oocyte structure and function 153 
prior to fertilisation.  154 
 155 
Hyperglycaemia induces apoptosis in follicles and COCs. The Akita mouse model 156 
carries an autosomal dominant mutation which results in the spontaneous 157 
development of diabetes (hypoinsulinaemia and hyperglycaemia (The Jackson 158 
Laboratory 2000); such mice have significantly higher proportions of apoptotic cells 159 
within ovarian follicles compared to control mice (Chang et al. 2005); a result also 160 
observed in a streptozotocin-induced diabetic mouse model. Increased apoptosis 161 
within the ovary and COC may partly be due to the up-regulation of expression of 162 
several cell death signalling proteins (TRAIL and KILLER) found in cumulus cells 163 
from diabetic mice (Chang et al. 2005).  164 
 165 
Oocyte size is also affected, with oocytes from diabetic and obese mice smaller than 166 
control oocytes (Chang et al. 2005; Jungheim et al. 2010). Smaller oocyte size is 167 
also observed in mice even under mild hyperglycaemia that is below the diabetic 168 
threshold (Jungheim et al. 2010). The link between maternal hyperglycaemia and 169 
small oocytes also translates to humans, with smaller oocytes collected from obese 170 
women undergoing in vitro fertilisation (IVF) or intracytoplasmic sperm injection 171 
(ICSI) than from non-obese women (Marquard et al. 2011). Data from human studies 172 
of patients undergoing IVF has shown that both small oocyte size and cumulus cell 173 
apoptosis correlate with poor pregnancy outcomes (Arnot et al. 1995; Bergh et al. 174 
1998; Nataprawira et al. 1992; Wittmaack et al. 1994). Mitochondria are the most 175 
abundant organelle in the mammalian oocyte and early embryo, and play a critical 176 
role in oocyte maturation and early embryo development through the provision of 177 
ATP (Van Blerkom 2011). Impairment of mitochondrial function in general is strongly 178 
associated with diabetes (Rolo and Palmeira 2006); a family history of diabetes was 179 
associated with decreased ATP synthesis even before the onset of impaired glucose 180 
tolerance (pre-diabetes) in some individuals (Petersen et al. 2004). The mitochondria 181 
in oocytes from diabetic mice have altered structure and distribution, reduced energy 182 
production (as measured by tricarboxylic acid  (TCA) cycle metabolites) and an 183 
increased mitochondrial DNA copy number (Wang and Moley 2010; Wang et al. 184 
2009); interestingly, the latter is usually associated with increased oocyte 185 
competence (El Shourbagy et al. 2006; Santos et al. 2006; Tamassia et al. 2004). 186 
These authors attributed the increased copy number to a compensatory mechanism 187 
to ensure the adequate supply of ATP, possibly due to increased mitochondrial 188 
demand. Structurally, mitochondria in oocytes from streptozotocin-induced and Akita 189 
strain diabetic mice have a narrowed intermembrane space compared to those from 190 
non-diabetic mice. Other abnormalities included completely ruptured outer 191 
membranes and swelling of the mitochondria, indicative of impending mitochondria-192 
dependent apoptosis (Wang et al. 2009). 193 
 194 
Several mitochondria-related parameters (ATP, ROS, pyruvate dehydrogenase) 195 
have been associated with meiotic spindle assembly and chromosome alignment in 196 
oocytes (Johnson et al. 2007; Zhang et al. 2006). Many studies have shown delayed 197 
and decreased completion of meiotic maturation in oocytes from diabetic mice 198 
(Chang et al. 2005; Colton et al. 2002; Diamond et al. 1989; Kim et al. 2007; 199 
Ratchford et al. 2007; Wang et al. 2010), accompanied by spindle defects and 200 
chromosome misalignments during maturation (Chang et al. 2005). In mouse 201 
oocytes, the spindle defects are diverse but include extra asters and mono-polar 202 
spindles, with chromosome misalignments manifesting as one or more 203 
chromosomes displaced from the equator (Cheng et al. 2011; Wang et al. 2009). 204 
Subsequently, Cheng et al. (2011) performed islet transplantation (containing the 205 
insulin-producing beta cells) from non-diabetic to diabetic mice, and were able to 206 
reverse the effects of maternal diabetes on the observed spindle defects, 207 
chromosome misalignments and incidence of aneuploidy.  208 
 209 
The endoplasmic reticulum (ER) is especially important in maturing oocytes for its 210 
role in Ca2+ signalling for the completion of meiosis, and preventing polyspermy 211 
(Runft et al. 2002). The distribution of the ER changes during the course of oocyte 212 
maturation and early embryo development. This is disrupted in oocytes and embryos 213 
from diabetic mice, possibly contributing to the reduced oocyte quality associated 214 
with hyperglycaemia (Zhang et al. 2013). Many of the adverse effects of 215 
hyperglycaemia, such as insulin resistance, are mediated through the PI3-K 216 
pathway. However, this does not appear to be the case with oocyte developmental 217 
competence, as down-regulation of the PI3-K pathway using inhibitors in bovine 218 
oocytes during maturation was unable to replicate the detrimental effects observed 219 
under hyperglycaemic conditions (Sutton-McDowall et al. 2006). 220 
 221 
While excess glucose is clearly detrimental, the supply of some glucose is a 222 
fundamental requirement for oocyte and embryo health (Sutton et al. 2003), and its 223 
absence reduces levels of meiotic resumption, (Downs and Hudson 2000; Funahashi 224 
et al. 2008; Hashimoto et al. 2000; mouse, cow, pig), cumulus expansion (Frank et 225 
al. 2012; Nandi et al. 2008; mouse, buffalo, sheep) and embryo development 226 
(Hendryx and Wordinger 1979; Wongsrikeao et al. 2006; pig, mouse). Glucose 227 
concentration throughout development must be maintained at an optimal level, and 228 
excess or absence results in reduced oocyte developmental competence (Thompson 229 
2006). This concept is supported by recent work with mouse (Frank et al. 2012) and 230 
buffalo (Kumar et al. 2013) in vitro-matured oocytes, showing that optimal embryo 231 
development is achieved using a relatively low glucose concentration (dependent on 232 
species; mouse and buffalo 1 mM and 5.6 mM respectively) while higher 233 
concentrations (up to 30 mM, and 10 mM, respectively), or the absence of glucose, 234 
decreased development.  235 
 236 
3. Glucose metabolism in the maturing cumulus-oocyte complex (COC)  237 
The two cell types within the COC have different metabolic activities and glucose is 238 
consumed almost exclusively by the cumulus cells, due to the higher expression of 239 
key glucose transporters such as the insulin-sensitive facilitative glucose transporter 240 
SLC2A4, which has a high affinity for glucose (Nishimoto et al. 2006; Roberts et al. 241 
2004; Williams et al. 2001; cow, mouse sheep). There are several documented 242 
pathways for glucose metabolism in the COC (Fig. 1), and with the exception of the 243 
polyol pathway all of these begin with the phosphorylation of glucose to glucose-6-244 
phosphate by hexokinase (Sutton-McDowall et al. 2010).  245 
 246 
Glycolysis accounts for the majority of the glucose taken up by the COC (Downs and 247 
Utecht 1999; Kumar et al. 2013; mouse, buffalo), and the rate of 248 
phosphofructokinase (PFK; one of the rate-limiting enzymes of glycolysis) activity 249 
remains constant throughout oocyte maturation (Cetica et al. 2002; Colton et al. 250 
2003; Sutton-McDowall et al. 2010; cow, mouse). Cumulus cells have high PFK 251 
activity (Downs et al. 1996; mouse) whereas the oocyte itself has low levels of 252 
glucose consumption and limited PFK activity (Cetica et al. 2002; Harris et al. 2009; 253 
mouse, cow); instead relying on the cumulus cells to supply it with carboxylic acids 254 
(Biggers et al. 1967; Sutton-McDowall et al. 2010 mouse, cow). Indeed, in bovine 255 
COCs, cumulus cells metabolise 23-fold more glucose per ml tissue per hour than 256 
oocytes (Thompson 2006). Pyruvate is the preferred nutrient of the oocyte itself for 257 
energy production, and it is metabolised via the TCA cycle, fuelling oxidative 258 
phosphorylation (Biggers et al. 1967; Steeves and Gardner 1999).  259 
 260 
A recent study measuring ATP in single mouse oocytes (Dalton et al. 2013) found 261 
variation in the amount of ATP from mitrochondria (measured in denuded oocytes) 262 
throughout in vitro maturation, including a notable drop in the level immediately 263 
following germinal vesicle breakdown (GVBD). When cumulus-enclosed oocytes 264 
were examined, the magnitude of the reduction in ATP following GVBD was 265 
reduced, and this effect was ablated with the inhibition of gap junction 266 
communication, highlighting the importance of the metabolic support provided by the 267 
cumulus cells to the oocyte. 268 
 269 
The pentose phosphate pathway (PPP) accounts for relatively little of the glucose 270 
consumed by the COC (Sutton-McDowall et al. 2010), but plays a vital role in meiotic 271 
maturation of the oocyte (Downs et al. 1996; Sutton-McDowall et al. 2005); higher 272 
G6PDH (glucose-6-phosphate dehydrogenase; the enzyme which catalyses the first 273 
step of the PPP) activity in bovine oocytes compared to cumulus cells suggesting 274 
that the important site for PPP activity may be in the oocyte itself (Cetica et al. 2002). 275 
The PPP metabolises glucose to produce NADPH, an intracellular reductant that 276 
aids in the protection of cells from damage by reactive oxygen species by 277 
participating in the reduction of oxidised glutathione (Xu et al. 2005). Another product 278 
of the PPP is phosphoribosylpyrophosphate, the sugar component for de novo 279 
nucleic acid synthesis (Banfalvi 2006), hence participating in the regulation of oocyte 280 
meiotic maturation (Downs et al. 1998; Downs et al. 1996; mouse). In mice, inhibition 281 
of  G6PDH results in a reduction in the number of oocytes ovulated, decreased 282 
blastocyst development and a subsequent reduction in litter size (Jimenez et al. 283 
2013). Interestingly, in buffalo, the expression pattern of G6PDH during oocyte in 284 
vitro maturation and early embryo development is predictive of quality and 285 
developmental competence (Kumar et al. 2013). 286 
 287 
The polyol pathway involves the conversion of glucose to sorbitol by aldose 288 
reductase followed by the production of fructose by sorbitol dehydrogenase.  Aldose 289 
reductase has a low affinity for glucose and under normal conditions very little 290 
glucose is directed down this pathway. Little is known about the activity of this 291 
pathway within the COC (Sutton-McDowall et al. 2010).  292 
 293 
The other significant pathway for glucose metabolism is the hexosamine 294 
biosynthesis pathway (Fig. 1), which will be the focus of the rest of this review. 295 
 296 
4. The hexosamine biosynthesis pathway (HBP) 297 
Under normoglycaemic conditions, approximately 1-3% of total glucose consumed 298 
by somatic cells is directed down the HBP (Marshall et al. 1991; Sayeski and Kudlow 299 
1996), which produces UDP-GlcNAc (Marshall et al. 2004). The HBP is a highly 300 
conserved pathway which functions in all cell types as a link between nutrient levels 301 
and cell signalling, using UDP-GlcNAc for β-O-linked glycosylation (Zachara and 302 
Hart 2004b). This link has been studied in most detail in relation to the glucose-303 
mediated development of insulin resistance (Marshall et al. 1991; Yang et al. 2008). 304 
UDP-GlcNAc is the substrate for the majority of glycosylation in the cell, creating 305 
mucopolysaccharides; large glycosaminoglycan chains which are incorporated into 306 
proteoglycans in mucus, connective tissue, skin, tendons, cartilage and ligaments 307 
(Anderson et al. 2005) and importantly for reproduction, extra cellular matrix 308 
synthesis for cumulus cell mucification (Gutnisky et al. 2007) (Fig. 1).  309 
 310 
Glutamine:fructose-6-phosphate amidotransferase (GFPT) catalyses the first step of 311 
the HBP, converting fructose-6-phosphate to glucosamine-6-phosphate using 312 
glutamine as a co-factor (Badet et al. 1987). GFPT is the rate-limiting enzyme of the 313 
HBP and is strongly allosterically inhibited by the end-product, UDP-GlcNAc 314 
(Milewski 2002). There are two isoforms of GFPT, which share ~75% homology in 315 
both humans and mice and both produce functional GFPT enzymes (Oki et al. 316 
1999). The main difference between the two is localisation; in adult tissues, GFPT1 317 
is more strongly expressed in the kidney and pancreas, while GFPT2 is preferentially 318 
expressed in the central nervous system. Both are expressed in the heart and 319 
placenta (DeHaven et al. 2001; Oki et al. 1999; Sayeski et al. 1994; Zhou et al. 320 
1995). There is very limited data available on Gfpt1 and Gfpt2 expression in 321 
reproductive tissues, however both isoforms have been detected in the cumulus cells 322 
of bovine COCs matured in vitro (Caixeta et al. 2013). 323 
 324 
4.1. β-O-linked glycosylation 325 
An alternative fate of UDP-GlcNAc is its attachment to the hydroxyl groups or serine 326 
or threonine residues of proteins; a post-translational modification called β-O-linked 327 
glycosylation or O-GlcNAcylation (for review see (Wells et al. 2003)). In contrast to 328 
the glycosaminoglycan-type glycosylation, the O-GlcNAc modification consists of a 329 
single O-linked N-acetylglucosamine residue, with no further additions such that a 330 
chain is not formed. First discovered in 1984 (Torres and Hart 1984), it is now 331 
estimated that β-O-linked glycosylation is as widespread as phosphorylation, and is 332 
found in all multicellular eukaryotes examined to date (Comer and Hart 2000; 333 
Roquemore et al. 1994; Wells et al. 2001). Thousands of key cytosolic and nuclear 334 
proteins are known to be modified by O-GlcNAc: in one study, out of approximately 335 
5,000 human sequences examined from SWISS-PROT, over 4,600 had at least one 336 
predicted O-GlcNAc site (Gupta and Brunak 2002). While the enzymes of β-O-linked 337 
glycosylation have been characterized and purified, to date there is no known 338 
recognition sequence for O-GlcNAc attachment (Julenius et al. 2005). A ‘fuzzy’ motif 339 
is marked by the close proximity of proline and valine residues; a downstream tract 340 
of serines and no leucine or glutamine residues in the near vicinity (Gupta and 341 
Brunak 2002). Although β-O-linked glycosylation is recognised as one of the most 342 
common forms of post-translational modification of proteins, characterisation of this 343 
modification has only recently been pursued because of its comparatively recent 344 
discovery, as well as the lack of suitable tools for studying it (β-O-linked glycosylation 345 
was discovered nearly 30 years ago). In contrast, phosphorylation has been known 346 
for 70 years (Copeland et al. 2013; Whelan and Hart 2003). 347 
 348 
4.1.1. Enzymes of β-O-linked glycosylation 349 
Only one enzyme for the addition of O-GlcNAc has been discovered; O-linked β-N-350 
acetylglucosaminyltransferase (OGT) (Kreppel et al. 1997b; Kreppel and Hart 1999; 351 
Lubas et al. 1997; Lubas and Hanover 2000). Its counterpart, O-GlcNAc specific β-352 
N-acetylglucosaminidase (O-GlcNAcase) is the only known enzyme which removes 353 
O-GlcNAc from molecules (Dong and Hart 1994; Gao et al. 2001; Wells et al. 2002). 354 
In comparison, there are hundreds of kinases and phosphatases (Webb 1992). Both 355 
of these β-O-linked glycosylation enzymes have been highly conserved throughout 356 
evolution (Gao et al. 2001; Kreppel et al. 1997b; Lubas et al. 1997). The crystal 357 
structure of human OGT in complex with its substrates has recently been resolved 358 
(Lazarus et al. 2011).  359 
 360 
Consistent with observations of nuclear and cytoplasmic O-GlcNAc-modified 361 
proteins, OGT is not found in the golgi secretory pathway with enzymes for other 362 
types of glycosylation, but instead is concentrated in the nucleocytoplasmic 363 
compartment (Holt and Hart 1986). The OGT gene is X-linked, mapping to region 364 
q13 which is often associated with neurodegenerative disorders (Shafi et al. 2000). 365 
Interestingly, OGT itself is regulated by its own intrinsic β-O-linked glycosylation 366 
state, and is hyperglycosylated in response to elevated glucose (Akimoto et al. 367 
2001), however the sites of β-O-linked glycosylation and their effect on the 368 
enzymatic activity of OGT remain unknown (Kreppel et al. 1997a). 369 
 370 
4.1.2. β-O-linked glycosylation and phosphorylation 371 
As well as the single residue nature of β-O-linked glycosylation, are other 372 
characteristics which make it more similar to phosphorylation than to other forms of 373 
glycosylation. Like phosphorylation, the addition/removal of O-GlcNAc turns over 374 
more rapidly than the polypeptide backbone (Chou et al. 1992; Roquemore et al. 375 
1996), and has been shown to cycle on and off proteins on a time scale similar to 376 
that for phosphorylation/dephosphorylation (Slawson et al. 2006). Together with its 377 
enzymes, it is localised to cytosolic and nuclear proteins, in contrast to 378 
glycosaminoglycans which are secreted or membrane-bound (Van den Steen et al. 379 
1998; Vosseller et al. 2001; Zachara and Hart 2004a). Unlike other forms of 380 
glycosylation that have highly complex, long-chain structures, β-O-linked 381 
glycosylation is reversible (Van den Steen et al. 1998) and hence more likely to be 382 
involved in dynamic cell signalling (Vosseller et al. 2001). Indeed, O-GlcNAc 383 
regulates protein function in a very similar manner to phosphorylation, with the two 384 
different modifications often targeting the same or adjacent sites on a protein in what 385 
has been described as a yin-yang relationship (Butkinaree et al. 2010; Comer and 386 
Hart 2000; Haltiwanger et al. 1997; Wang et al. 2008; Whelan and Hart 2003).  387 
 388 
A reciprocal relationship between global phosphorylation and β-O-linked 389 
glycosylation levels has been demonstrated in several cell lines (Comer and Hart 390 
2001; Lefebvre et al. 1999). In addition, there are site-specific observations of 391 
phosphorylation and β-O-linked glycosylation regulating each other at the same or 392 
neighbouring sites on many proteins, including the oestrogen receptor β (Cheng et 393 
al. 2000), the SV40 T antigen (Medina et al. 1998), c-Myc (Chou et al. 1995) and 394 
RNA polymerase II (Kelly et al. 1993). The transcription factor specificity protein 1 395 
(SP1) is modified by O-GlcNAc, and in glomerular mesangial cells inhibiting O-396 
GlcNAcase results in a 4-fold increase in β-O-linked glycosylated SP1 and a 30% 397 
decrease in serine/threonine phosphorylated SP1 (Haltiwanger et al. 1998). A similar 398 
result was shown in aortic endothelial cells, where hyperglycaemia induces a 1.7-fold 399 
increase in β-O-linked glycosylated SP1 and a 70-80% decrease in phosphorylated 400 
SP1 (Du et al. 2000). 401 
 402 
4.2. Glucosamine as a hexosamine pathway substrate 403 
Glucosamine is a hexose sugar which is transported into cells via facilitated glucose 404 
transporters (Uldry et al. 2002) but differs from glucose by the presence of an amino 405 
group. Glucosamine is widely used as a hyperglycaemic mimetic (Marshall et al. 406 
2004; Monauni et al. 2000), as it is metabolised via the HBP but is converted straight 407 
to glucosamine-6-phosphate, thereby bypassing the slowest (rate-limiting) step of 408 
the pathway when glucose is used as the starting substrate (Fig. 1)  (Marshall et al. 409 
2005; Nelson et al. 2000; Parker et al. 2004; Patti et al. 1999; Sutton-McDowall et al. 410 
2006). Hence, glucosamine is a more potent stimulator of HBP activity than glucose; 411 
in adipocytes glucosamine is estimated to be at least 40 times more effective than 412 
glucose at mediating desensitization of the insulin-responsive transport system 413 
(Marshall et al. 1991). Consistent with these reports, mouse COCs matured in the 414 
presence of 2.5 mM glucosamine expand 4-fold more than those matured under 415 
control conditions (5.6 mM glucose), as a result of increased substrate in the 416 
glucosamine group for hyaluronic acid synthesis (Chen et al. 1993). In bovine COCs 417 
matured in vitro, the addition of glucosamine reduces total glucose consumption 418 
(Sutton-McDowall et al. 2004). One explanation is that while glucose-6-phosphate is 419 
a potent inhibitor of hexokinase, glucosamine-6-phosphate is a relatively weak one 420 
(Virkamaki and Yki-Jarvinen 1999), and more glucosamine-6-phosphate may be able 421 
to accumulate before the same level of negative feedback on hexokinase is reached 422 
(Pantaleon et al. 2010). Furthermore, during embryo development, treatment with 423 
0.2 mM glucosamine had the same negative effect on mouse blastocyst 424 
development as 27 mM glucose (Pantaleon et al. 2010).  425 
 426 
4.3. Currently known roles of the HBP 427 
The HBP and β-O-linked glycosylation are known regulators of essential cellular 428 
processes such as the cell cycle (Haltiwanger and Philipsberg 1997; Slawson and 429 
Hart 2003; Slawson et al. 2002; Yang et al. 2012); protein transcription and 430 
translation (Comer and Hart 2000; Datta et al. 2001). Such regulation occurs during 431 
oocyte maturation (Eppig 1996; Grondahl 2008; Kang and Han 2011). Aberrant Β-O-432 
linked glycosylation is associated with a myriad of disease states (for reviews see 433 
(Hart et al. 2007; Yang and Suh 2013)) and in general, β-O-linked glycosylation is 434 
increased in unhealthy or pathological states compared to healthy cells. This is also 435 
the case when cells are exposed to many different types of stress in vitro. For 436 
example, O-GlcNAc levels increase rapidly in response to heat shock, ethanol, UV, 437 
hypoxia, reductive, oxidative or osmotic stress (Zachara et al. 2004). This may be a 438 
protective mechanism, as decreased OGT and β-O-linked glycosylation levels result 439 
in cells that are less tolerant of stress (Hart et al. 2007; Zachara et al. 2004). Altered 440 
glycosylation status has long been associated with tumour growth (Fuster and Esko 441 
2005), and many oncogene and tumor suppressor proteins are modified by O-442 
GlcNAc (Chou and Hart 2001). 443 
 444 
The most widely studied example of the HBP as a fuel-sensing pathway coupled to 445 
cell signalling is in diabetes mellitus. First implicated in the development of type 2 446 
diabetes in 1991 (Marshall et al. 1991), the HBP plays a role in both of the major 447 
pathologies of diabetes: insulin resistance and the decline in pancreatic β-cell 448 
function. Insulin resistance is defined as the reduced ability of insulin to lower blood 449 
glucose, and it is well known that increasing flux through the HBP, raising O-GlcNAc 450 
levels using PUGNAc (an inhibitor of O-GlcNAcase) or overexpression of OGT 451 
results in insulin resistance (Akimoto et al. 2007; Arias and Cartee 2005; Arias et al. 452 
2004; McClain et al. 2002; Vosseller et al. 2002). This is in part due to impaired 453 
glucose transport into cells expressing the insulin-responsive transporter SLC2A4 454 
(primarily skeletal and heart muscle and adipocytes) (Buse 2006). While there is no 455 
change in SLC2A4 expression in cells exposed to hyperglycaemia or glucosamine 456 
(Nelson et al. 2000), accelerated degradation of the protein occurs in these 457 
conditions (Thomson et al. 1997) as well as defective translocation of SLC2A4 to the 458 
plasma membrane in cultured insulin-resistant  adipocytes (Nelson et al. 2000; Park 459 
et al. 2005).  460 
 461 
 462 
4.4. The HBP and early development 463 
Hexosamine pathway activity plays a crucial role in early development. Homozygous 464 
mutant mice for glucosamine-6-phosphate transferase (an enzyme acting 465 
downstream of GFPT in the HBP) die at 7.5 dpc after experiencing general 466 
proliferation defects (Nelkin et al. 1980). Moreover, β-O-linked glycosylation itself is 467 
vital for life even at the single cell level, with targeted deletion of the OGT locus in 468 
mice resulting in an ablation of embryonic stem cell viability (Shafi et al. 2000). 469 
 470 
A recent study examining Gfpt2 in developing mouse embryos found evidence of 471 
expression in the foregut endoderm at 8.5 dpc, and the myocardium underlying the 472 
cardiac cushions at 9.5 dpc (Woolford 2012). By 10.5 dpc expression in the heart 473 
was largely lost and instead focused on the optic vesicle. No expression was seen in 474 
the placenta, while Gfpt1 was observed here at 9.5 dpc. The author proposed that 475 
the function of Gfpt2 at 8.5 dpc may be to facilitate O-GlcNAc modulation of 476 
fibroblast growth factor signalling important to heart development. At 9.5 dpc, 477 
glycosaminoglycan formation is part of cardiac cushion formation through swelling of 478 
the extracellular matrix. Interestingly, there was no effect on embryo or pup survival 479 
in mice generated with homozygous gene trap insertions (creating functionally null 480 
alleles of Gfpt2), suggesting that Gfpt2 expression is not crucial to early mouse 481 
development and may be compensated for by Gfpt1.  482 
 483 
Studies examining the role of the HBP in early embryo development have shown that 484 
excess flux during this time, whether as a result of hyperglycaemia or glucosamine 485 
treatment, induces negative consequences for the embryo. For example, Pantaleon 486 
et al. (2010) showed that 27 mM glucose (hyperglycaemia) or 0.2 mM  glucosamine  487 
added to mouse embryo culture media from 18 – 90 h post-hCG, reduced embryo 488 
development, increased apoptosis and decreased cell number in the resulting 489 
blastocysts. BADGP (benzyl-2-acetamido-2-deoxy-α-D-galactopyranoside, an 490 
inhibitor of OGT) at 2 mM rescued all these phenotypes in the hyperglycaemia 491 
treatment group, although only mild improvement was seen in the glucosamine 492 
group. This may reflect the relative potencies of each hexose in their capacity to 493 
stimulate the HBP and UDP-GlcNAc production (Marshall et al. 1991). Zygotes 494 
cultured in the complete absence of glucose failed entirely to form blastocysts. With 495 
a combination of control medium (0.2 mM glucose) and 5 mM glucosamine, 496 
blastocyst formation was completely ablated, while BADGP treatment in control 497 
medium alone reduced blastocyst development by 34% (Pantaleon et al. 2010). 498 
Taken together, these results imply that any significant perturbation of HBP flux 499 
during early cleavage is detrimental to embryo development. Additionally, the 500 
presence of 0.2 mM glucosamine in the absence of glucose stimulated embryo 501 
development by 50% compared to controls in which glucose was absent, indicating 502 
that while some HBP flux is beneficial, other pathways which do not metabolise 503 
glucosamine must also play roles during this period of development. 504 
 505 
It also appears that the requirement for HBP flux during early cleavage can be 506 
satisfied with a short pulse of glucose or glucosamine at the cleavage stage (50 – 64 507 
h post-hCG) (Pantaleon et al. 2008). Using mouse zygotes, the complete absence of 508 
glucose in culture to the blastocyst stage ablated embryo development, and as 509 
before, caused an increase in apoptosis and a decrease in blastocyst cell number. 510 
However, a 2 – 3 h pulse of glucose or glucosamine was enough to reverse 511 
development and apoptosis insults, although blastocyst cell number did not recover.  512 
 513 
Pantaleon et al. (2008) also observed that a decrease in the mouse embryo in both 514 
mRNA and apical protein of the high-affinity glucose transporter SLC2A3 in the 515 
absence of glucose. This transporter is required for blastocyst formation, and hence 516 
it was hypothesised that the variations in HBP flux may affect SLC2A3 expression or 517 
function. Indeed, the glucose or glucosamine pulse was also able to restore both 518 
mRNA and protein expression of this transporter. Because of the ability of 519 
glucosamine to substitute for glucose in this role and the implication of the 520 
involvement of the HBP, the authors went on to examine the effect of inhibition of 521 
GFPT around the time of the pulse (30 min before, during, and 30 min after) using 522 
azaserine (which prevents entry of glucose into the HBP by inhibiting GFPT; Fig. 1). 523 
In the presence of azaserine, a glucose pulse was ineffective; however, a 524 
glucosamine pulse was able to rescue embryo development and SLC2A3 525 
expression. These results strongly implicate the HBP as having a critical and 526 
temporally-sensitive role during early embryogenesis, at least in part through 527 
modulation of SLC2A3 levels. The pulse model used by Pantaleon et al. (2008) was 528 
based on studies by Chatot et al. (1994) who found a similar result. Mouse zygotes 529 
cultured in the absence of glucose failed to develop into blastocysts, however a 530 
pulse of glucose as short as 1 minute in duration was sufficient to support 531 
development to the blastocyst stage, if administered between 30 – 54 h culture 532 
(approximately 56 – 80 h post-hCG). This time frame was refined from an earlier 533 
study, in which the authors found that glucose addition at 24 h culture was too early, 534 
and 72 h culture too late, to support blastocyst development (Chatot et al. 1989). 535 
 536 
Glucosamine 6-phosphate, the first intermediate in the HBP, is a competitive inhibitor 537 
of G6PDH (a key enzyme in the oxidative arm of the PPP). Since inhibition of 538 
G6PDH using dehydroepiandrosterone (DHEA) is known to block decidualization of 539 
endometrial stromal cells both in vitro and in vivo (Frolova et al. 2011; human, 540 
mouse). Tsai et al. (2013) tested this concept in vivo in mice, using a 60-day release 541 
glucosamine pellet implanted in one uterine horn. Mice with the glucosamine pellet 542 
produced fewer live pups per litter than those with a control pellet, and once the 543 
active life of the pellet had expired the number returned to normal. The authors 544 
believe this may represent a potential non-hormonal, reversible contraceptive which 545 
acts by preventing the endometrium from becoming receptive to embryo 546 
implantation.  547 
 548 
4.5. The HBP in oocyte maturation 549 
 550 
4.5.1. Hexosamine biosynthesis in the COC - mucification and cumulus 551 
expansion 552 
As the COC matures following the ovulatory LH surge, the cumulus cells around the 553 
oocyte undergo mucification and the matrix expands (Chen et al. 1993; Eppig 1981; 554 
Salustri et al. 1989); a phenomenon which assists in the transfer of the COC to the 555 
oviduct after ovulation and participates in fertilization (Tanghe et al. 2002). There is 556 
strong evidence for a role for cumulus expansion in follicle rupture and ovulation 557 
(Chen et al. 1993; Russell and Robker 2007), as mice with defective cumulus matrix 558 
formation are sub-fertile or infertile, primarily due to an impairment of ovulation 559 
(Robker et al. 2000). The precise mechanisms behind this phenomenon are 560 
unknown, although it has been suggested that expansion may promote the 561 
detachment of COCs from granulosa cells in preparation for ovulation, as well as 562 
providing a semi-solid mass to assist in propulsion of the COC from the follicle (Chen 563 
et al. 1993). It has also been demonstrated that cumulus cells from expanded, pre-564 
ovulatory mouse COCs are more adherent to extracellular matrices such as 565 
collagen, found in the follicle wall, and may have proteolytic activity, thus actively 566 
participating via migratory mechanisms in their own release from the follicle (Alvino 567 
2010). 568 
 569 
In vitro, cumulus cell expansion itself is not a direct predictor of oocyte 570 
developmental competence (Ali and Sirard 2002; Luciano et al. 2004), however IVM 571 
conditions which promote developmental competence (the inclusion of  follicle-572 
stimulating hormone, epidermal growth factor and serum in the medium) also tend to 573 
promote cumulus expansion (Assidi et al. 2013; Merriman et al. 1998; Mikkelsen et 574 
al. 2001). This concept is supported by recent evidence showing that bone 575 
morphogenetic protein 15 or fibroblast growth factor 10, both of which increase 576 
developmental competence of bovine COCs in vitro (Carrette et al. 2001; Sturmey et 577 
al. 2009; Wilkinson and Gilbert 2004), increase mRNA of both Gfpt1 and Gfpt2 578 
(Sutton-McDowall et al. 2012).  579 
 580 
UDP-GlcNAc is an essential substrate for the cumulus cell production of hyaluronic 581 
acid by, the extracellular matrix glycosaminoglycan which supports the expansion of 582 
the cumulus matrix. In vitro, cumulus expansion is positively associated with the level 583 
of glucose present in maturation medium (Frank et al. 2012; mouse), and towards 584 
the end of maturation, there is an unusually high up-regulation of HBP activity, with 585 
approximately 25% of the total glucose metabolised via this pathway (Sutton-586 
McDowall et al. 2004; cow). Preventing the entry of glucose into the HBP using an 587 
inhibitor of GFPT (6-diazo-5-oxo-L-norleucine) decreases cumulus expansion and 588 
reduces glucose uptake by bovine COCs (Gutnisky et al. 2007). Hence, to a degree, 589 
up-regulation of the HBP is essential for COC expansion. 590 
 591 
4.5.2. The role of O-GlcNAc in oocyte maturation 592 
As discussed, the role of the HBP in COC maturation was first studied in the context 593 
of the synthesis of hyaluronic acid during cumulus expansion (Chen et al. 1993; 594 
Sutton-McDowall et al. 2004). Using in vitro maturation, glucosamine treatment 595 
significantly decreases glucose consumption and incorporation of radiolabelled 596 
glucose into the extracellular matrix by bovine COCs, indicative of the preferential 597 
use of glucosamine for cumulus expansion (Sutton-McDowall et al. 2004).  598 
 599 
Using an in vivo model of peri-conception glucosamine treatment, younger mice (8 600 
weeks) had a reduced litter size, while older mice (16 weeks) were not affected in 601 
this way but had litters with reduced fetal weight and increased congenital 602 
abnormalities (Schelbach et al. 2013). The detrimental effects of glucosamine 603 
treatment during oocyte in vitro maturation manifest post-compaction, with 604 
glucosamine treatment during IVM having no effect on meiotic maturation in cow, pig 605 
or mouse; however, in all species, morula and blastocyst development were severely 606 
inhibited in these conditions (Schelbach et al. 2010; Sutton-McDowall et al. 2006). A 607 
decrease in cleavage to the two-cell stage was also observed in the mouse study in 608 
the presence of glucosamine (Schelbach et al. 2010). BADGP supplementation in 609 
IVM media rescued embryo development from COCs cultured in the presence of 610 
glucosamine in each study in a dose-dependent manner, highlighting the contribution 611 
of the HBP to the developmental competence of mammalian oocytes.  612 
 613 
Recently we further dissected the impact of HBP flux on mouse COC maturation, 614 
and found that metabolism through this pathway of either glucose or glucosamine 615 
was crucial for subsequent developmental competence (Frank et al. 2012). 616 
Glucosamine alone was unable to support embryo development, and at higher levels 617 
(2.5 and 5 mM) was detrimental to measures of oocyte competence, supporting the 618 
notion that an intermediate level of β-O-linked glycosylation is optimal for cell viability 619 
(Yang et al. 2012). Glucosamine 6-phosphate is a competitive inhibitor of glucose-6-620 
phosphate dehydrogenase (a key enzyme in the oxidative arm of the pentose 621 
phosphate pathway; PPP) (Kanji et al. 1976), and significantly less glucose is 622 
metabolised through the PPP in COCs from diabetic mice compared to controls 623 
(Colton et al. 2003). This downregulation of the PPP in response to upregulation of 624 
the HBP may contribute to the decline in meiotic maturation completion observed in 625 
oocytes from diabetic mice (Chang et al. 2005; Colton et al. 2002; Diamond et al. 626 
1989; Kim et al. 2007; Ratchford et al. 2007; Wang et al. 2010) or those exposed to 627 
high levels of glucosamine (Frank et al. 2012).  628 
 629 
We also observed a temporal effect of HBP stimulation. The presence of glucose 630 
during the first hour of mouse in vitro maturation was critical to subsequent 631 
development, but glucosamine alone was able to substitute for glucose during this 632 
first hour. This result suggests that the HBP may be the only critical pathway during 633 
this period, although stimulation of the other pathways using glucose was necessary 634 
during the subsequent 17 hours for continued development (Frank et al. 2012). This 635 
is compatible with the dynamic nature of β-O-linked glycosylation, cycling on and off 636 
proteins at a rapid rate in response to environmental factors, especially glucose 637 
levels. Culture for one hour in the absence of glucose and subsequent perturbations 638 
in normal β-O-linked glycosylation patterns appears to be sufficient to cause long-639 
term damage to the embryo. 640 
 641 
 642 
To date there has been little research on the role of specifically β-O-linked 643 
glycosylation in oocyte maturation, as opposed to overall HBP activity, which also 644 
manifests in observations of cumulus expansion. It has been demonstrated that 645 
following exposure to glucosamine, β-O-linked glycosylation is elevated in bovine 646 
(Sutton-McDowall et al. 2006) as well as mouse (Fig. 2) COCs. We have also 647 
performed time-course experiments which revealed changes in β-O-linked 648 
glycosylation levels throughout in vitro maturation of mouse COCs even under 649 
control conditions (Frank et al., unpublished data). This is consistent with previously 650 
published reports showing that as Xenopus oocytes mature, the level of total cellular 651 
O-GlcNAc declines (Slawson et al. 2002).  652 
 653 
Using mass spectrometry, we have identified 15 candidate proteins in mouse COCs 654 
as targets of this modification. One of these, Heat shock protein 90, was shown to 655 
have a detrimental effect on oocyte competence in its O-GlcNAcylated form, and 656 
interacts with OGT itself, possibly as a molecular chaperone (Frank et al. 2013). This 657 
work demonstrated for the first time the presence of OGT in the COC, and its 658 
potential role as a regulator of oocyte competence, in response to a hyperglycaemic 659 
environment. 660 
 661 
5. Conclusions 662 
The peri-conceptual environment is known to have a major impact on the 663 
developmental competence of oocytes and embryos and hence on subsequent fetal 664 
development. In particular, it is well known that hyperglycaemic conditions during this 665 
time are detrimental to subsequent embryo and fetal health, however the 666 
mechanisms for this effect are poorly understood. While the importance of the HBP 667 
as a fuel sensing and regulatory signalling pathway and O-GlcNAc as the effector is 668 
becoming increasingly evident in a wide variety of fields, very little is known about 669 
the contribution of the HBP to oocyte and embryo early development. However, this 670 
lack of understanding is gradually being addressed, the mechanisms by which 671 
hyperglycaemia compromises fertility are becoming clearer and providing possible 672 
therapeutic targets.  673 
  674 
Materials and Methods 675 
Collection and in vitro maturation of mouse COCs was performed as described 676 
previously (Frank et al. 2012Frank et al. 2012). At 6 h maturation, COCs were fixed 677 
in 4% paraformaldehyde, then adhered to Cell-Tak (Becton Dickinson, NJ, USA) –678 
coated slides and permeabilised in 0.25% Triton X-100 (USB Corporation, OH, 679 
USA). Blocking was performed for 2 h using 10% goat serum (Jackson 680 
ImmunoResearch, PA, USA) and 0.2% Tween 20 (Sigma Aldrich, MO, USA) and 681 
incubated overnight at 4°C with 1/250 primary antibody (CTD110.6  for anti-O-682 
GlcNAc; Covance, NJ, USA) in blocking solution. On day 2 COCs were washed and 683 
incubated for 2 h with 1/250 secondary antibody (Alexa Fluor 488 goat anti-mouse 684 
IgM (Life Technologies, CA, USA) and 4’,6-diamidino-2-phenylindole (DAPI) for 685 
nuclear staining (Sigma Aldrich). COCs were mounted under a coverslip using 686 
fluorescence mounting medium (Dako, Glostrup, Denmark) and examined on an 687 
Olympus Fluoview FV10i laser scanning confocal microscope (Olympus, Tokyo, 688 
Japan). Both colours for images were collected simultaneously, and laser intensity 689 
settings remained uniform. Excitation/emission wavelengths in nm were 405/461 and 690 
473/520 for DAPI and Alexa Fluor 488 respectively. A 60 x objective lens, type 691 
UPLSAP60xW, was used with 1.5 or 3.5 x digital zoom (for individual magnifications 692 
see Fig. 2). 693 
 694 
References 695 
Akimoto Y, Hart GW, Wells L, Vosseller K, Yamamoto K, Munetomo E, Ohara-Imaizumi M, Nishiwaki 696 
C, Nagamatsu S, Hirano H, Kawakami H. 2007. Elevation of the post-translational 697 
modification of proteins by O-linked N-acetylglucosamine leads to deterioration of the 698 
glucose-stimulated insulin secretion in the pancreas of diabetic Goto-Kakizaki rats. 699 
Glycobiology 17(2):127-140. 700 
Akimoto Y, Kreppel LK, Hirano H, Hart GW. 2001. Hyperglycemia and the O-GlcNAc transferase in rat 701 
aortic smooth muscle cells: elevated expression and altered patterns of O-GlcNAcylation. 702 
Arch Biochem Biophys 389(2):166-175. 703 
Ali A, Sirard MA. 2002. Effect of the absence or presence of various protein supplements on further 704 
development of bovine oocytes during in vitro maturation. Biol Reprod 66(4):901-905. 705 
Alvino ER. 2010. The role of the cumulus oocyte complex during ovulation. Adelaide: The University 706 
of Adelaide. 707 
Anderson JW, Nicolosi RJ, Borzelleca JF. 2005. Glucosamine effects in humans: a review of effects on 708 
glucose metabolism, side effects, safety considerations and efficacy. Food Chem Toxicol 709 
43(2):187-201. 710 
Arias EB, Cartee GD. 2005. Relationship between protein O-linked glycosylation and insulin-711 
stimulated glucose transport in rat skeletal muscle following calorie restriction or exposure 712 
to O-(2-acetamido-2-deoxy-d-glucopyranosylidene)amino-N-phenylcarbamate. Acta Physiol 713 
Scand 183(3):281-289. 714 
Arias EB, Kim J, Cartee GD. 2004. Prolonged incubation in PUGNAc results in increased protein O-715 
Linked glycosylation and insulin resistance in rat skeletal muscle. Diabetes 53(4):921-930. 716 
Arnot AM, Vandekerckhove P, DeBono MA, Rutherford AJ. 1995. Follicular volume and number 717 
during in-vitro fertilization: association with oocyte developmental capacity and pregnancy 718 
rate. Human reproduction 10(2):256-261. 719 
Assidi M, Richard FJ, Sirard MA. 2013. FSH in vitro versus LH in vivo: similar genomic effects on the 720 
cumulus. Journal of ovarian research 6(1):68. 721 
Au HK, Yeh TS, Kao SH, Tzeng CR, Hsieh RH. 2005. Abnormal mitochondrial structure in human 722 
unfertilized oocytes and arrested embryos. Annals of the New York Academy of Sciences 723 
1042:177-185. 724 
Baccetti B, La Marca A, Piomboni P, Capitani S, Bruni E, Petraglia F, De Leo V. 2002. Insulin-725 
dependent diabetes in men is associated with hypothalamo-pituitary derangement and with 726 
impairment in semen quality. Human reproduction 17(10):2673-2677. 727 
Badet B, Vermoote P, Haumont PY, Lederer F, LeGoffic F. 1987. Glucosamine synthetase from 728 
Escherichia coli: purification, properties, and glutamine-utilizing site location. Biochemistry 729 
26(7):1940-1948. 730 
Banfalvi G. 2006. Why ribose was selected as the sugar component of nucleic acids. DNA Cell Biol 731 
25(3):189-196. 732 
Bavister BD, Squirrell JM. 2000. Mitochondrial distribution and function in oocytes and early 733 
embryos. Hum Reprod 15 Suppl 2:189-198. 734 
Becerra JE, Khoury MJ, Cordero JF, Erickson JD. 1990. Diabetes mellitus during pregnancy and the 735 
risks for specific birth defects: a population-based case-control study. Pediatrics 85(1):1-9. 736 
Bell R, Glinianaia SV, Tennant PW, Bilous RW, Rankin J. 2012. Peri-conception hyperglycaemia and 737 
nephropathy are associated with risk of congenital anomaly in women with pre-existing 738 
diabetes: a population-based cohort study. Diabetologia. 739 
Bergh C, Broden H, Lundin K, Hamberger L. 1998. Comparison of fertilization, cleavage and 740 
pregnancy rates of oocytes from large and small follicles. Human reproduction 13(7):1912-741 
1915. 742 
Biggers JD, Whittingham DG, Donahue RP. 1967. The pattern of energy metabolism in the mouse 743 
oocyte and zygote. Proceedings of the National Academy of Sciences of the United States of 744 
America 58(2):560-567. 745 
Boney CM, Verma A, Tucker R, Vohr BR. 2005. Metabolic syndrome in childhood: association with 746 
birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics 115(3):e290-747 
296. 748 
Brownlee M. 2001. Biochemistry and molecular cell biology of diabetic complications. Nature 749 
414(6865):813-820. 750 
Buse MG. 2006. Hexosamines, insulin resistance, and the complications of diabetes: current status. 751 
American journal of physiology Endocrinology and metabolism 290(1):E1-E8. 752 
Butkinaree C, Park K, Hart GW. 2010. O-linked beta-N-acetylglucosamine (O-GlcNAc): Extensive 753 
crosstalk with phosphorylation to regulate signaling and transcription in response to 754 
nutrients and stress. Biochimica et biophysica acta 1800(2):96-106. 755 
Caixeta ES, Sutton-McDowall ML, Gilchrist RB, Thompson JG, Price CA, Machado MF, Lima PF, 756 
Buratini J. 2013. Bone morphogenetic protein 15 and fibroblast growth factor 10 enhance 757 
cumulus expansion, glucose uptake, and expression of genes in the ovulatory cascade during 758 
in vitro maturation of bovine cumulus-oocyte complexes. Reproduction 146(1):27-35. 759 
Carrette O, Nemade RV, Day AJ, Brickner A, Larsen WJ. 2001. TSG-6 is concentrated in the 760 
extracellular matrix of mouse cumulus oocyte complexes through hyaluronan and inter-761 
alpha-inhibitor binding. Biol Reprod 65(1):301-308. 762 
Casson IF, Clarke CA, Howard CV, McKendrick O, Pennycook S, Pharoah PO, Platt MJ, Stanisstreet M, 763 
van Velszen D, Walkinshaw S. 1997. Outcomes of pregnancy in insulin dependent diabetic 764 
women: results of a five year population cohort study. Bmj 315(7103):275-278. 765 
Cetica P, Pintos L, Dalvit G, Beconi M. 2002. Activity of key enzymes involved in glucose and 766 
triglyceride catabolism during bovine oocyte maturation in vitro. Reproduction 124(5):675-767 
681. 768 
Chalepakis G, Goulding M, Read A, Strachan T, Gruss P. 1994. Molecular basis of splotch and 769 
Waardenburg Pax-3 mutations. Proceedings of the National Academy of Sciences of the 770 
United States of America 91(9):3685-3689. 771 
Chang AS, Dale AN, Moley KH. 2005. Maternal diabetes adversely affects preovulatory oocyte 772 
maturation, development, and granulosa cell apoptosis. Endocrinology 146(5):2445-2453. 773 
Chatot CL, Lewis-Williams J, Torres I, Ziomek CA. 1994. One-minute exposure of 4-cell mouse 774 
embryos to glucose overcomes morula block in CZB medium. Mol Reprod Dev 37(4):407-775 
412. 776 
Chatot CL, Ziomek CA, Bavister BD, Lewis JL, Torres I. 1989. An improved culture medium supports 777 
development of random-bred 1-cell mouse embryos in vitro. J Reprod Fertil 86(2):679-688. 778 
Chen L, Russell PT, Larsen WJ. 1993. Functional significance of cumulus expansion in the mouse: 779 
roles for the preovulatory synthesis of hyaluronic acid within the cumulus mass. Mol Reprod 780 
Dev 34(1):87-93. 781 
Cheng PP, Xia JJ, Wang HL, Chen JB, Wang FY, Zhang Y, Huang X, Zhang QJ, Qi ZQ. 2011. Islet 782 
transplantation reverses the effects of maternal diabetes on mouse oocytes. Reproduction 783 
141(4):417-424. 784 
Cheng X, Cole RN, Zaia J, Hart GW. 2000. Alternative O-glycosylation/O-phosphorylation of the 785 
murine estrogen receptor beta. Biochemistry 39(38):11609-11620. 786 
Cheung WD, Hart GW. 2008. AMP-activated protein kinase and p38 MAPK activate O-GlcNAcylation 787 
of neuronal proteins during glucose deprivation. The Journal of biological chemistry 788 
283(19):13009-13020. 789 
Chou CF, Smith AJ, Omary MB. 1992. Characterization and dynamics of O-linked glycosylation of 790 
human cytokeratin 8 and 18. The Journal of biological chemistry 267(6):3901-3906. 791 
Chou TY, Hart GW. 2001. O-linked N-acetylglucosamine and cancer: messages from the glycosylation 792 
of c-Myc. Adv Exp Med Biol 491:413-418. 793 
Chou TY, Hart GW, Dang CV. 1995. c-Myc is glycosylated at threonine 58, a known phosphorylation 794 
site and a mutational hot spot in lymphomas. The Journal of biological chemistry 795 
270(32):18961-18965. 796 
Colton SA, Humpherson PG, Leese HJ, Downs SM. 2003. Physiological changes in oocyte-cumulus cell 797 
complexes from diabetic mice that potentially influence meiotic regulation. Biol Reprod 798 
69(3):761-770. 799 
Colton SA, Pieper GM, Downs SM. 2002. Altered meiotic regulation in oocytes from diabetic mice. 800 
Biology of reproduction 67(1):220-231. 801 
Comer FI, Hart GW. 2000. O-Glycosylation of nuclear and cytosolic proteins. Dynamic interplay 802 
between O-GlcNAc and O-phosphate. The Journal of biological chemistry 275(38):29179-803 
29182. 804 
Comer FI, Hart GW. 2001. Reciprocity between O-GlcNAc and O-phosphate on the carboxyl terminal 805 
domain of RNA polymerase II. Biochemistry 40(26):7845-7852. 806 
Copeland RJ, Han G, Hart GW. 2013. O-GlcNAcomics-Revealing roles of O-GlcNAcylation in disease 807 
mechanisms and development of potential diagnostics. Proteomics Clinical applications. 808 
Cornblath M, Schwartz R. 1976. Disorders of carbohydrate metabolism in infancy. Major Probl Clin 809 
Pediatr 3:1-483. 810 
Dalton CM, Szabadkai G, Carroll J. 2013. Dynamic measurement of ATP in single oocytes: Impact of 811 
stage of maturation and cumulus cells on ATP levels and rates of consumption. J Cell Physiol. 812 
Datta R, Choudhury P, Bhattacharya M, Soto Leon F, Zhou Y, Datta B. 2001. Protection of translation 813 
initiation factor eIF2 phosphorylation correlates with eIF2-associated glycoprotein p67 levels 814 
and requires the lysine-rich domain I of p67. Biochimie 83(10):919-931. 815 
DeHaven JE, Robinson KA, Nelson BA, Buse MG. 2001. A novel variant of glutamine: fructose-6-816 
phosphate amidotransferase-1 (GFAT1) mRNA is selectively expressed in striated muscle. 817 
Diabetes 50(11):2419-2424. 818 
Diamond MP, Moley KH, Pellicer A, Vaughn WK, DeCherney AH. 1989. Effects of streptozotocin- and 819 
alloxan-induced diabetes mellitus on mouse follicular and early embryo development. 820 
Journal of reproduction and fertility 86(1):1-10. 821 
Dokras A, Baredziak L, Blaine J, Syrop C, VanVoorhis BJ, Sparks A. 2006. Obstetric outcomes after in 822 
vitro fertilization in obese and morbidly obese women. Obstetrics and gynecology 108(1):61-823 
69. 824 
Dong DL, Hart GW. 1994. Purification and characterization of an O-GlcNAc selective N-acetyl-beta-D-825 
glucosaminidase from rat spleen cytosol. The Journal of biological chemistry 269(30):19321-826 
19330. 827 
Downs SM, Hudson ED. 2000. Energy substrates and the completion of spontaneous meiotic 828 
maturation. Zygote 8(4):339-351. 829 
Downs SM, Humpherson PG, Leese HJ. 1998. Meiotic induction in cumulus cell-enclosed mouse 830 
oocytes: involvement of the pentose phosphate pathway. Biol Reprod 58(4):1084-1094. 831 
Downs SM, Humpherson PG, Martin KL, Leese HJ. 1996. Glucose utilization during gonadotropin-832 
induced meiotic maturation in cumulus cell-enclosed mouse oocytes. Mol Reprod Dev 833 
44(1):121-131. 834 
Downs SM, Utecht AM. 1999. Metabolism of radiolabeled glucose by mouse oocytes and oocyte-835 
cumulus cell complexes. Biol Reprod 60(6):1446-1452. 836 
Du XL, Edelstein D, Rossetti L, Fantus IG, Goldberg H, Ziyadeh F, Wu J, Brownlee M. 2000. 837 
Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine 838 
pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 839 
glycosylation. Proceedings of the National Academy of Sciences of the United States of 840 
America 97(22):12222-12226. 841 
Dunne FP, Brydon P, Smith T, Essex M, Nicholson H, Dunn J. 1999. Pre-conception diabetes care in 842 
insulin-dependent diabetes mellitus. QJM : monthly journal of the Association of Physicians 843 
92(3):175-176. 844 
Dunning KR, Cashman K, Russell DL, Thompson JG, Norman RJ, Robker RL. 2010. Beta-oxidation is 845 
essential for mouse oocyte developmental competence and early embryo development. Biol 846 
Reprod 83(6):909-918. 847 
El-Sayed YY, Lyell DJ. 2001. New therapies for the pregnant patient with diabetes. Diabetes Technol 848 
Ther 3(4):635-640. 849 
El Shourbagy SH, Spikings EC, Freitas M, St John JC. 2006. Mitochondria directly influence fertilisation 850 
outcome in the pig. Reproduction 131(2):233-245. 851 
Eppig JJ. 1981. Regulation by sulfated glycosaminoglycans of the expansion of cumuli oophori 852 
isolated from mice. Biol Reprod 25(3):599-608. 853 
Eppig JJ. 1996. Coordination of nuclear and cytoplasmic oocyte maturation in eutherian mammals. 854 
Reprod Fertil Dev 8(4):485-489. 855 
Farrell T, Neale L, Cundy T. 2002. Congenital anomalies in the offspring of women with type 1, type 2 856 
and gestational diabetes. Diabet Med 19(4):322-326. 857 
Fleming TP, Kwong WY, Porter R, Ursell E, Fesenko I, Wilkins A, Miller DJ, Watkins AJ, Eckert JJ. 2004. 858 
The embryo and its future. Biology of reproduction 71(4):1046-1054. 859 
Frank LA, Sutton-McDowall ML, Brown HM, Russell DL, Gilchrist RB, Thompson JG. 2013. 860 
Hyperglycaemia perturbs mouse oocyte developmental competence via beta-O-linked 861 
glycosylation of Heat shock protein 90. Hum Reprod. 862 
Frank LA, Sutton-McDowall ML, Russell DL, Wang X, Feil DK, Gilchrist RB, Thompson JG. 2012. Effect 863 
of varying glucose and glucosamine concentration in vitro on mouse oocyte maturation and 864 
developmental competence. Reprod Fertil Dev. 865 
Frolova AI, O'Neill K, Moley KH. 2011. Dehydroepiandrosterone inhibits glucose flux through the 866 
pentose phosphate pathway in human and mouse endometrial stromal cells, preventing 867 
decidualization and implantation. Mol Endocrinol 25(8):1444-1455. 868 
Funahashi H, Koike T, Sakai R. 2008. Effect of glucose and pyruvate on nuclear and cytoplasmic 869 
maturation of porcine oocytes in a chemically defined medium. Theriogenology 70(7):1041-870 
1047. 871 
Fuster MM, Esko JD. 2005. The sweet and sour of cancer: glycans as novel therapeutic targets. Nat 872 
Rev Cancer 5(7):526-542. 873 
Gao Y, Wells L, Comer FI, Parker GJ, Hart GW. 2001. Dynamic O-glycosylation of nuclear and cytosolic 874 
proteins: cloning and characterization of a neutral, cytosolic beta-N-acetylglucosaminidase 875 
from human brain. The Journal of biological chemistry 276(13):9838-9845. 876 
Gardner DK, Leese HJ. 1990. Concentrations of nutrients in mouse oviduct fluid and their effects on 877 
embryo development and metabolism in vitro. J Reprod Fertil 88(1):361-368. 878 
Greene MF. 1999. Spontaneous abortions and major malformations in women with diabetes 879 
mellitus. Semin Reprod Endocrinol 17(2):127-136. 880 
Grondahl C. 2008. Oocyte maturation. Basic and clinical aspects of in vitro maturation (IVM) with 881 
special emphasis of the role of FF-MAS. Danish medical bulletin 55(1):1-16. 882 
Guerin A, Nisenbaum R, Ray JG. 2007. Use of maternal glycosylated hemoglobin concentration to 883 
estimate the risk of congenital anomalies in the offspring of women with pre-pregnancy 884 
diabetes mellitus. Diabetes Care In Press. 885 
Gupta R, Brunak S. 2002. Prediction of glycosylation across the human proteome and the correlation 886 
to protein function. Pac Symp Biocomput:310-322. 887 
Gutnisky C, Dalvit GC, Pintos LN, Thompson JG, Beconi MT, Cetica PD. 2007. Influence of hyaluronic 888 
acid synthesis and cumulus mucification on bovine oocyte in vitro maturation, fertilisation 889 
and embryo development. Reprod Fertil Dev 19(3):488-497. 890 
Haltiwanger RS, Busby S, Grove K, Li S, Mason D, Medina L, Moloney D, Philipsberg G, Scartozzi R. 891 
1997. O-glycosylation of nuclear and cytoplasmic proteins: regulation analogous to 892 
phosphorylation? Biochemical and biophysical research communications 231(2):237-242. 893 
Haltiwanger RS, Grove K, Philipsberg GA. 1998. Modulation of O-linked N-acetylglucosamine levels 894 
on nuclear and cytoplasmic proteins in vivo using the peptide O-GlcNAc-beta-N-895 
acetylglucosaminidase inhibitor O-(2-acetamido-2-deoxy-D-glucopyranosylidene)amino-N-896 
phenylcarbamate. The Journal of biological chemistry 273(6):3611-3617. 897 
Haltiwanger RS, Philipsberg GA. 1997. Mitotic arrest with nocodazole induces selective changes in 898 
the level of O-linked N-acetylglucosamine and accumulation of incompletely processed N-899 
glycans on proteins from HT29 cells. The Journal of biological chemistry 272(13):8752-8758. 900 
Harris SE, Leese HJ, Gosden RG, Picton HM. 2009. Pyruvate and oxygen consumption throughout the 901 
growth and development of murine oocytes. Molecular reproduction and development 902 
76(3):231-238. 903 
Hart GW, Housley MP, Slawson C. 2007. Cycling of O-linked beta-N-acetylglucosamine on 904 
nucleocytoplasmic proteins. Nature 446(7139):1017-1022. 905 
Hashimoto S, Minami N, Yamada M, Imai H. 2000. Excessive concentration of glucose during in vitro 906 
maturation impairs the developmental competence of bovine oocytes after in vitro 907 
fertilization: relevance to intracellular reactive oxygen species and glutathione contents. Mol 908 
Reprod Dev 56(4):520-526. 909 
Hedderson MM, Ferrara A, Sacks DA. 2003. Gestational diabetes mellitus and lesser degrees of 910 
pregnancy hyperglycemia: association with increased risk of spontaneous preterm birth. 911 
Obstet Gynecol 102(4):850-856. 912 
Hendryx JT, Wordinger RJ. 1979. The effects of decreased glucose concentrations on the in vitro 913 
development of the post-blastocyst mouse embryo in a fetal calf serum- or bovine serum 914 
albumin-supplemented medium. Experientia 35(11):1508-1510. 915 
Holing EV, Beyer CS, Brown ZA, Connell FA. 1998. Why don't women with diabetes plan their 916 
pregnancies? Diabetes care 21(6):889-895. 917 
Holt GD, Hart GW. 1986. The subcellular distribution of terminal N-acetylglucosamine moieties. 918 
Localization of a novel protein-saccharide linkage, O-linked GlcNAc. J Biol Chem 919 
261(17):8049-8057. 920 
Horal M, Zhang Z, Stanton R, Virkamaki A, Loeken MR. 2004. Activation of the hexosamine pathway 921 
causes oxidative stress and abnormal embryo gene expression: involvement in diabetic 922 
teratogenesis. Birth Defects Res A Clin Mol Teratol 70(8):519-527. 923 
Isono T. 2011. O-GlcNAc-Specific Antibody CTD110.6 Cross-Reacts with N-GlcNAc(2)-Modified 924 
Proteins Induced under Glucose Deprivation. PLoS One 6(4):e18959. 925 
Jawerbaum A, White V. 2010. Animal models in diabetes and pregnancy. Endocr Rev 31(5):680-701. 926 
Jimenez PT, Frolova AI, Chi MM, Grindler NM, Willcockson AR, Reynolds KA, Zhao Q, Moley KH. 2013. 927 
DHEA-mediated inhibition of the pentose phosphate pathway alters oocyte lipid metabolism 928 
in mice. Endocrinology. 929 
Johnson MT, Freeman EA, Gardner DK, Hunt PA. 2007. Oxidative metabolism of pyruvate is required 930 
for meiotic maturation of murine oocytes in vivo. Biol Reprod 77(1):2-8. 931 
Julenius K, Molgaard A, Gupta R, Brunak S. 2005. Prediction, conservation analysis, and structural 932 
characterization of mammalian mucin-type O-glycosylation sites. Glycobiology 15(2):153-933 
164. 934 
Jungheim ES, Moley KH. 2010. Current knowledge of obesity's effects in the pre- and 935 
periconceptional periods and avenues for future research. American journal of obstetrics 936 
and gynecology 203(6):525-530. 937 
Jungheim ES, Schoeller EL, Marquard KL, Louden ED, Schaffer JE, Moley KH. 2010. Diet-induced 938 
obesity model: abnormal oocytes and persistent growth abnormalities in the offspring. 939 
Endocrinology 151(8):4039-4046. 940 
Kang JG, Park SY, Ji S, Jang I, Park S, Kim HS, Kim SM, Yook JI, Park YI, Roth J, Cho JW. 2009. O-GlcNAc 941 
protein modification in cancer cells increases in response to glucose deprivation through 942 
glycogen degradation. The Journal of biological chemistry 284(50):34777-34784. 943 
Kang MK, Han SJ. 2011. Post-transcriptional and post-translational regulation during mouse oocyte 944 
maturation. BMB reports 44(3):147-157. 945 
Kanji MI, Toews ML, Carper WR. 1976. A kinetic study of glucose-6-phosphate dehydrogenase. The 946 
Journal of biological chemistry 251(8):2258-2262. 947 
Kelly WG, Dahmus ME, Hart GW. 1993. RNA polymerase II is a glycoprotein. Modification of the 948 
COOH-terminal domain by O-GlcNAc. The Journal of biological chemistry 268(14):10416-949 
10424. 950 
Kim K, Kim CH, Moley KH, Cheon YP. 2007. Disordered meiotic regulation of oocytes by duration of 951 
diabetes mellitus in BBdp rat. Reprod Sci 14(5):467-474. 952 
Kreppel LK, Blomberg MA, Hart GW. 1997a. Dynamic glycosylation of nuclear and cytosolic proteins. 953 
Cloning and characterization of a unique O-GlcNAc transferase with multiple 954 
tetratricopeptide repeats. The Journal of biological chemistry 272(14):9308-9315. 955 
Kreppel LK, Blomberg MA, Hart GW. 1997b. Dynamic glycosylation of nuclear and cytosolic proteins. 956 
Cloning and characterization of a unique O-GlcNAc transferase with multiple 957 
tetratricopeptide repeats. The Journal of biological chemistry 272(14):9308-9315. 958 
Kreppel LK, Hart GW. 1999. Regulation of a cytosolic and nuclear O-GlcNAc transferase. Role of the 959 
tetratricopeptide repeats. The Journal of biological chemistry 274(45):32015-32022. 960 
Kumar P, Rajput S, Verma A, De S, Datta TK. 2013. Expression pattern of glucose metabolism genes in 961 
relation to development rate of buffalo (Bubalus bubalis) oocytes and in vitro-produced 962 
embryos. Theriogenology 80(8):914-922. 963 
Lapolla A, Dalfra MG, Di Cianni G, Bonomo M, Parretti E, Mello G. 2008a. A multicenter Italian study 964 
on pregnancy outcome in women with diabetes. Nutr Metab Cardiovasc Dis 18(4):291-297. 965 
Lapolla A, Dalfra MG, Fedele D. 2008b. Pregnancy complicated by type 2 diabetes: an emerging 966 
problem. Diabetes Res Clin Pract 80(1):2-7. 967 
Lazarus MB, Nam Y, Jiang J, Sliz P, Walker S. 2011. Structure of human O-GlcNAc transferase and its 968 
complex with a peptide substrate. Nature 469(7331):564-567. 969 
Lea RG, McCracken JE, McIntyre SS, Smith W, Baird JD. 1996. Disturbed development of the 970 
preimplantation embryo in the insulin-dependent diabetic BB/E rat. Diabetes 45(11):1463-971 
1470. 972 
Leese HJ, Baumann CG, Brison DR, McEvoy TG, Sturmey RG. 2008. Metabolism of the viable 973 
mammalian embryo: quietness revisited. Mol Hum Reprod 14(12):667-672. 974 
Leese HJ, Lenton EA. 1990. Glucose and lactate in human follicular fluid: concentrations and 975 
interrelationships. Human reproduction 5(8):915-919. 976 
Lefebvre T, Alonso C, Mahboub S, Dupire MJ, Zanetta JP, Caillet-Boudin ML, Michalski JC. 1999. 977 
Effect of okadaic acid on O-linked N-acetylglucosamine levels in a neuroblastoma cell line. 978 
Biochimica et biophysica acta 1472(1-2):71-81. 979 
Lubas WA, Frank DW, Krause M, Hanover JA. 1997. O-Linked GlcNAc transferase is a conserved 980 
nucleocytoplasmic protein containing tetratricopeptide repeats. The Journal of biological 981 
chemistry 272(14):9316-9324. 982 
Lubas WA, Hanover JA. 2000. Functional expression of O-linked GlcNAc transferase. Domain 983 
structure and substrate specificity. The Journal of biological chemistry 275(15):10983-10988. 984 
Luciano AM, Modina S, Vassena R, Milanesi E, Lauria A, Gandolfi F. 2004. Role of intracellular cyclic 985 
adenosine 3',5'-monophosphate concentration and oocyte-cumulus cells communications 986 
on the acquisition of the developmental competence during in vitro maturation of bovine 987 
oocyte. Biol Reprod 70(2):465-472. 988 
Marquard KL, Stephens SM, Jungheim ES, Ratts VS, Odem RR, Lanzendorf S, Moley KH. 2011. 989 
Polycystic ovary syndrome and maternal obesity affect oocyte size in in vitro 990 
fertilization/intracytoplasmic sperm injection cycles. Fertil Steril 95(6):2146-2149, 2149 991 
e2141. 992 
Marshall S, Bacote V, Traxinger RR. 1991. Discovery of a metabolic pathway mediating glucose-993 
induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in 994 
the induction of insulin resistance. J Biol Chem 266(8):4706-4712. 995 
Marshall S, Nadeau O, Yamasaki K. 2004. Dynamic actions of glucose and glucosamine on 996 
hexosamine biosynthesis in isolated adipocytes: differential effects on glucosamine 6-997 
phosphate, UDP-N-acetylglucosamine, and ATP levels. J Biol Chem 279(34):35313-35319. 998 
Marshall S, Nadeau O, Yamasaki K. 2005. Glucosamine-induced activation of glycogen biosynthesis in 999 
isolated adipocytes. Evidence for a rapid allosteric control mechanism within the 1000 
hexosamine biosynthesis pathway. The Journal of biological chemistry 280(12):11018-11024. 1001 
McClain DA, Lubas WA, Cooksey RC, Hazel M, Parker GJ, Love DC, Hanover JA. 2002. Altered glycan-1002 
dependent signaling induces insulin resistance and hyperleptinemia. Proceedings of the 1003 
National Academy of Sciences of the United States of America 99(16):10695-10699. 1004 
Medina L, Grove K, Haltiwanger RS. 1998. SV40 large T antigen is modified with O-linked N-1005 
acetylglucosamine but not with other forms of glycosylation. Glycobiology 8(4):383-391. 1006 
Merriman JA, Whittingham DG, Carroll J. 1998. The effect of follicle stimulating hormone and 1007 
epidermal growth factor on the developmental capacity of in-vitro matured mouse oocytes. 1008 
Human reproduction 13(3):690-695. 1009 
Metwally M, Ong KJ, Ledger WL, Li TC. 2008. Does high body mass index increase the risk of 1010 
miscarriage after spontaneous and assisted conception? A meta-analysis of the evidence. 1011 
Fertil Steril 90(3):714-726. 1012 
Middleton P, Crowther CA, Simmonds L, Muller P. 2010. Different intensities of glycaemic control for 1013 
pregnant women with pre-existing diabetes. Cochrane Database Syst Rev 9:CD008540. 1014 
Mikkelsen AL, Host E, Blaabjerg J, Lindenberg S. 2001. Maternal serum supplementation in culture 1015 
medium benefits maturation of immature human oocytes. Reprod Biomed Online 3(2):112-1016 
116. 1017 
Milewski S. 2002. Glucosamine-6-phosphate synthase--the multi-facets enzyme. Biochim Biophys 1018 
Acta 1597(2):173-192. 1019 
Miller E, Hare JW, Cloherty JP, Dunn PJ, Gleason RE, Soeldner JS, Kitzmiller JL. 1981. Elevated 1020 
maternal hemoglobin A1c in early pregnancy and major congenital anomalies in infants of 1021 
diabetic mothers. The New England journal of medicine 304(22):1331-1334. 1022 
Mills JL, Baker L, Goldman AS. 1979. Malformations in infants of diabetic mothers occur before the 1023 
seventh gestational week. Implications for treatment. Diabetes 28(4):292-293. 1024 
Mills JL, Simpson JL, Driscoll SG, Jovanovic-Peterson L, Van Allen M, Aarons JH, Metzger B, Bieber FR, 1025 
Knopp RH, Holmes LB, et al. 1988. Incidence of spontaneous abortion among normal women 1026 
and insulin-dependent diabetic women whose pregnancies were identified within 21 days of 1027 
conception. The New England journal of medicine 319(25):1617-1623. 1028 
Moley KH. 1999. Diabetes and preimplantation events of embryogenesis. Semin Reprod Endocrinol 1029 
17(2):137-151. 1030 
Moley KH, Chi MM, Knudson CM, Korsmeyer SJ, Mueckler MM. 1998a. Hyperglycemia induces 1031 
apoptosis in pre-implantation embryos through cell death effector pathways. Nat Med 1032 
4(12):1421-1424. 1033 
Moley KH, Chi MM, Mueckler MM. 1998b. Maternal hyperglycemia alters glucose transport and 1034 
utilization in mouse preimplantation embryos. Am J Physiol 275(1 Pt 1):E38-47. 1035 
Moley KH, Vaughn WK, DeCherney AH, Diamond MP. 1991. Effect of diabetes mellitus on mouse pre-1036 
implantation embryo development. Journal of reproduction and fertility 93(2):325-332. 1037 
Monauni T, Zenti MG, Cretti A, Daniels MC, Targher G, Caruso B, Caputo M, McClain D, Del Prato S, 1038 
Giaccari A, Muggeo M, Bonora E, Bonadonna RC. 2000. Effects of glucosamine infusion on 1039 
insulin secretion and insulin action in humans. Diabetes 49(6):926-935. 1040 
Nandi S, Girish Kumar V, Manjunatha BM, Ramesh HS, Gupta PS. 2008. Follicular fluid concentrations 1041 
of glucose, lactate and pyruvate in buffalo and sheep, and their effects on cultured oocytes, 1042 
granulosa and cumulus cells. Theriogenology 69(2):186-196. 1043 
Nataprawira DS, Harada T, Sekijima A, Mio Y, Terakawa N. 1992. Assessment of follicular maturity by 1044 
follicular diameter and fluid volume in a program of in vitro fertilization and embryo 1045 
transfer. Asia Oceania J Obstet Gynaecol 18(3):225-230. 1046 
Nelkin B, Nichols C, Vogelstein B. 1980. Protein factor(s) from mitotic CHO cells induce meiotic 1047 
maturation in Xenopus laevis oocytes. FEBS Lett 109(2):233-238. 1048 
Nelson BA, Robinson KA, Buse MG. 2000. High glucose and glucosamine induce insulin resistance via 1049 
different mechanisms in 3T3-L1 adipocytes. Diabetes 49(6):981-991. 1050 
Nishimoto H, Matsutani R, Yamamoto S, Takahashi T, Hayashi KG, Miyamoto A, Hamano S, Tetsuka 1051 
M. 2006. Gene expression of glucose transporter (GLUT) 1, 3 and 4 in bovine follicle and 1052 
corpus luteum. J Endocrinol 188(1):111-119. 1053 
Norman JE, Reynolds RM. 2011. The consequences of obesity and excess weight gain in pregnancy. 1054 
The Proceedings of the Nutrition Society 70(4):450-456. 1055 
O'Brien TE, Ray JG, Chan WS. 2003. Maternal body mass index and the risk of preeclampsia: a 1056 
systematic overview. Epidemiology 14(3):368-374. 1057 
Oh W, Gelardi NL, Cha CJ. 1988. Maternal hyperglycemia in pregnant rats: its effect on growth and 1058 
carbohydrate metabolism in the offspring. Metabolism 37(12):1146-1151. 1059 
Oki T, Yamazaki K, Kuromitsu J, Okada M, Tanaka I. 1999. cDNA cloning and mapping of a novel 1060 
subtype of glutamine:fructose-6-phosphate amidotransferase (GFAT2) in human and mouse. 1061 
Genomics 57(2):227-234. 1062 
Pantaleon M, Scott J, Kaye PL. 2008. Nutrient sensing by the early mouse embryo: hexosamine 1063 
biosynthesis and glucose signaling during preimplantation development. Biol Reprod 1064 
78(4):595-600. 1065 
Pantaleon M, Tan HY, Kafer GR, Kaye PL. 2010. Toxic effects of hyperglycemia are mediated by the 1066 
hexosamine signaling pathway and o-linked glycosylation in early mouse embryos. Biol 1067 
Reprod 82(4):751-758. 1068 
Park SY, Ryu J, Lee W. 2005. O-GlcNAc modification on IRS-1 and Akt2 by PUGNAc inhibits their 1069 
phosphorylation and induces insulin resistance in rat primary adipocytes. Exp Mol Med 1070 
37(3):220-229. 1071 
Parker G, Taylor R, Jones D, McClain D. 2004. Hyperglycemia and inhibition of glycogen synthase in 1072 
streptozotocin-treated mice: role of O-linked N-acetylglucosamine. The Journal of biological 1073 
chemistry 279(20):20636-20642. 1074 
Patti ME, Virkamaki A, Landaker EJ, Kahn CR, Yki-Jarvinen H. 1999. Activation of the hexosamine 1075 
pathway by glucosamine in vivo induces insulin resistance of early postreceptor insulin 1076 
signaling events in skeletal muscle. Diabetes 48(8):1562-1571. 1077 
Pearson DW, Kernaghan D, Lee R, Penney GC. 2007. The relationship between pre-pregnancy care 1078 
and early pregnancy loss, major congenital anomaly or perinatal death in type I diabetes 1079 
mellitus. Bjog 114(1):104-107. 1080 
Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI. 2004. Impaired mitochondrial activity in the 1081 
insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 350(7):664-671. 1082 
Purcell SH, Moley KH. 2011. The impact of obesity on egg quality. J Assist Reprod Genet. 1083 
Ratchford AM, Chang AS, Chi MM, Sheridan R, Moley KH. 2007. Maternal diabetes adversely affects 1084 
AMP-activated protein kinase activity and cellular metabolism in murine oocytes. Am J 1085 
Physiol Endocrinol Metab 293(5):E1198-1206. 1086 
Ray JG, O'Brien TE, Chan WS. 2001. Preconception care and the risk of congenital anomalies in the 1087 
offspring of women with diabetes mellitus: a meta-analysis. QJM 94(8):435-444. 1088 
Reece EA, Homko CJ. 2000. Why do diabetic women deliver malformed infants? Clin Obstet Gynecol 1089 
43(1):32-45. 1090 
Rich-Edwards JW, Goldman MB, Willett WC, Hunter DJ, Stampfer MJ, Colditz GA, Manson JE. 1994. 1091 
Adolescent body mass index and infertility caused by ovulatory disorder. American journal of 1092 
obstetrics and gynecology 171(1):171-177. 1093 
Roberts R, Stark J, Iatropoulou A, Becker DL, Franks S, Hardy K. 2004. Energy substrate metabolism of 1094 
mouse cumulus-oocyte complexes: response to follicle-stimulating hormone is mediated by 1095 
the phosphatidylinositol 3-kinase pathway and is associated with oocyte maturation. Biol 1096 
Reprod 71(1):199-209. 1097 
Robker RL, Akison LK, Bennett BD, Thrupp PN, Chura LR, Russell DL, Lane M, Norman RJ. 2009. Obese 1098 
women exhibit differences in ovarian metabolites, hormones, and gene expression 1099 
compared with moderate-weight women. J Clin Endocrinol Metab 94(5):1533-1540. 1100 
Robker RL, Russell DL, Yoshioka S, Sharma SC, Lydon JP, O'Malley BW, Espey LL, Richards JS. 2000. 1101 
Ovulation: a multi-gene, multi-step process. Steroids 65(10-11):559-570. 1102 
Rolo AP, Palmeira CM. 2006. Diabetes and mitochondrial function: role of hyperglycemia and 1103 
oxidative stress. Toxicology and applied pharmacology 212(2):167-178. 1104 
Roquemore EP, Chevrier MR, Cotter RJ, Hart GW. 1996. Dynamic O-GlcNAcylation of the small heat 1105 
shock protein alpha B-crystallin. Biochemistry 35(11):3578-3586. 1106 
Roquemore EP, Chou TY, Hart GW. 1994. Detection of O-linked N-acetylglucosamine (O-GlcNAc) on 1107 
cytoplasmic and nuclear proteins. Methods in enzymology 230:443-460. 1108 
Runft LL, Jaffe LA, Mehlmann LM. 2002. Egg activation at fertilization: where it all begins. Dev Biol 1109 
245(2):237-254. 1110 
Russell DL, Robker RL. 2007. Molecular mechanisms of ovulation: co-ordination through the cumulus 1111 
complex. Human reproduction update 13(3):289-312. 1112 
Sadler TW, Hunter ES, 3rd, Balkan W, Horton WE, Jr. 1988. Effects of maternal diabetes on 1113 
embryogenesis. Am J Perinatol 5(4):319-326. 1114 
Salustri A, Yanagishita M, Hascall VC. 1989. Synthesis and accumulation of hyaluronic acid and 1115 
proteoglycans in the mouse cumulus cell-oocyte complex during follicle-stimulating 1116 
hormone-induced mucification. J Biol Chem 264(23):13840-13847. 1117 
Santos TA, El Shourbagy S, St John JC. 2006. Mitochondrial content reflects oocyte variability and 1118 
fertilization outcome. Fertil Steril 85(3):584-591. 1119 
Sayeski PP, Kudlow JE. 1996. Glucose metabolism to glucosamine is necessary for glucose 1120 
stimulation of transforming growth factor-alpha gene transcription. J Biol Chem 1121 
271(25):15237-15243. 1122 
Sayeski PP, Paterson AJ, Kudlow JE. 1994. The murine glutamine:fructose-6-phosphate 1123 
amidotransferase-encoding cDNA sequence. Gene 140(2):289-290. 1124 
Schaefer UM, Songster G, Xiang A, Berkowitz K, Buchanan TA, Kjos SL. 1997. Congenital 1125 
malformations in offspring of women with hyperglycemia first detected during pregnancy. 1126 
Am J Obstet Gynecol 177(5):1165-1171. 1127 
Schelbach CJ, Kind KL, Lane M, Thompson JG. 2010. Mechanisms contributing to the reduced 1128 
developmental competence of glucosamine-exposed mouse oocytes. Reprod Fertil Dev 1129 
22(5):771-779. 1130 
Schelbach CJ, Robker RL, Bennett BD, Gauld AD, Thompson JG, Kind KL. 2013. Altered pregnancy 1131 
outcomes in mice following treatment with the hyperglycaemia mimetic, glucosamine, 1132 
during the periconception period. Reprod Fertil Dev 25(2):405-416. 1133 
Seshiah V, Balaji V, Balaji MS, Paneerselvam A, Arthi T, Thamizharasi M, Datta M. 2007. Gestational 1134 
diabetes mellitus manifests in all trimesters of pregnancy. Diabetes Res Clin Pract 77(3):482-1135 
484. 1136 
Shafi R, Iyer SP, Ellies LG, O'Donnell N, Marek KW, Chui D, Hart GW, Marth JD. 2000. The O-GlcNAc 1137 
transferase gene resides on the X chromosome and is essential for embryonic stem cell 1138 
viability and mouse ontogeny. Proceedings of the National Academy of Sciences of the 1139 
United States of America 97(11):5735-5739. 1140 
Silverman BL, Metzger BE, Cho NH, Loeb CA. 1995. Impaired glucose tolerance in adolescent 1141 
offspring of diabetic mothers. Relationship to fetal hyperinsulinism. Diabetes care 18(5):611-1142 
617. 1143 
Slawson C, Hart GW. 2003. Dynamic interplay between O-GlcNAc and O-phosphate: the sweet side 1144 
of protein regulation. Curr Opin Struct Biol 13(5):631-636. 1145 
Slawson C, Housley MP, Hart GW. 2006. O-GlcNAc cycling: how a single sugar post-translational 1146 
modification is changing the way we think about signaling networks. J Cell Biochem 97(1):71-1147 
83. 1148 
Slawson C, Shafii S, Amburgey J, Potter R. 2002. Characterization of the O-GlcNAc protein 1149 
modification in Xenopus laevis oocyte during oogenesis and progesterone-stimulated 1150 
maturation. Biochim Biophys Acta 1573(2):121-129. 1151 
Steeves TE, Gardner DK. 1999. Metabolism of glucose, pyruvate, and glutamine during the 1152 
maturation of oocytes derived from pre-pubertal and adult cows. Molecular reproduction 1153 
and development 54(1):92-101. 1154 
Stothard KJ, Tennant PW, Bell R, Rankin J. 2009. Maternal overweight and obesity and the risk of 1155 
congenital anomalies: a systematic review and meta-analysis. Jama 301(6):636-650. 1156 
Sturmey RG, Reis A, Leese HJ, McEvoy TG. 2009. Role of fatty acids in energy provision during oocyte 1157 
maturation and early embryo development. Reproduction in domestic animals = 1158 
Zuchthygiene 44 Suppl 3:50-58. 1159 
Suhonen L, Hiilesmaa V, Teramo K. 2000. Glycaemic control during early pregnancy and fetal 1160 
malformations in women with type I diabetes mellitus. Diabetologia 43(1):79-82. 1161 
Sun QY, Wu GM, Lai L, Park KW, Cabot R, Cheong HT, Day BN, Prather RS, Schatten H. 2001. 1162 
Translocation of active mitochondria during pig oocyte maturation, fertilization and early 1163 
embryo development in vitro. Reproduction 122(1):155-163. 1164 
Sutton-McDowall ML, Feil D, Robker RL, Thompson JG, Dunning KR. 2012. Utilization of endogenous 1165 
fatty acid stores for energy production in bovine preimplantation embryos. Theriogenology 1166 
77(8):1632-1641. 1167 
Sutton-McDowall ML, Gilchrist RB, Thompson JG. 2004. Cumulus expansion and glucose utilisation 1168 
by bovine cumulus-oocyte complexes during in vitro maturation: the influence of 1169 
glucosamine and follicle-stimulating hormone. Reproduction 128(3):313-319. 1170 
Sutton-McDowall ML, Gilchrist RB, Thompson JG. 2005. Effect of hexoses and gonadotrophin 1171 
supplementation on bovine oocyte nuclear maturation during in vitro maturation in a 1172 
synthetic follicle fluid medium. Reproduction, fertility, and development 17(4):407-415. 1173 
Sutton-McDowall ML, Gilchrist RB, Thompson JG. 2010. The pivotal role of glucose metabolism in 1174 
determining oocyte developmental competence. Reproduction 139(4):685-695. 1175 
Sutton-McDowall ML, Mitchell M, Cetica P, Dalvit G, Pantaleon M, Lane M, Gilchrist RB, Thompson 1176 
JG. 2006. Glucosamine supplementation during in vitro maturation inhibits subsequent 1177 
embryo development: possible role of the hexosamine pathway as a regulator of 1178 
developmental competence. Biol Reprod 74(5):881-888. 1179 
Sutton ML, Gilchrist RB, Thompson JG. 2003. Effects of in-vivo and in-vitro environments on the 1180 
metabolism of the cumulus-oocyte complex and its influence on oocyte developmental 1181 
capacity. Hum Reprod Update 9(1):35-48. 1182 
Tamassia M, Nuttinck F, May-Panloup P, Reynier P, Heyman Y, Charpigny G, Stojkovic M, Hiendleder 1183 
S, Renard JP, Chastant-Maillard S. 2004. In vitro embryo production efficiency in cattle and 1184 
its association with oocyte adenosine triphosphate content, quantity of mitochondrial DNA, 1185 
and mitochondrial DNA haplogroup. Biol Reprod 71(2):697-704. 1186 
Tanghe S, Van Soom A, Nauwynck H, Coryn M, de Kruif A. 2002. Minireview: Functions of the 1187 
cumulus oophorus during oocyte maturation, ovulation, and fertilization. Mol Reprod Dev 1188 
61(3):414-424. 1189 
Taylor RP, Parker GJ, Hazel MW, Soesanto Y, Fuller W, Yazzie MJ, McClain DA. 2008. Glucose 1190 
deprivation stimulates O-GlcNAc modification of proteins through up-regulation of O-linked 1191 
N-acetylglucosaminyltransferase. J Biol Chem 283(10):6050-6057. 1192 
The Jackson Laboratory. 2000. New autosomal dominant diabetes model. JAX Communications. Bar 1193 
Harbor: The Jackson Laboratory,. 1194 
Thompson JG. 2006. The impact of nutrition of the cumulus oocyte complex and embryo on 1195 
subsequent development in ruminants. Journal of Reproduction and Development 1196 
52(1):169-175. 1197 
Thomson MJ, Williams MG, Frost SC. 1997. Development of insulin resistance in 3T3-L1 adipocytes. 1198 
The Journal of biological chemistry 272(12):7759-7764. 1199 
Thouas GA, Trounson AO, Jones GM. 2006. Developmental effects of sublethal mitochondrial injury 1200 
in mouse oocytes. Biol Reprod 74(5):969-977. 1201 
Torres CR, Hart GW. 1984. Topography and polypeptide distribution of terminal N-acetylglucosamine 1202 
residues on the surfaces of intact lymphocytes. Evidence for O-linked GlcNAc. The Journal of 1203 
biological chemistry 259(5):3308-3317. 1204 
Tsai JH, Schulte M, O'Neill K, Chi MM, Frolova AI, Moley KH. 2013. Glucosamine inhibits 1205 
decidualization of human endometrial stromal cells and decreases litter sizes in mice. Biol 1206 
Reprod 89(1):16. 1207 
Uldry M, Ibberson M, Hosokawa M, Thorens B. 2002. GLUT2 is a high affinity glucosamine 1208 
transporter. FEBS Lett 524(1-3):199-203. 1209 
Unwin N, Shaw J, Zimmet P, Alberti KG. 2002. Impaired glucose tolerance and impaired fasting 1210 
glycaemia: the current status on definition and intervention. Diabet Med 19(9):708-723. 1211 
Van Blerkom J. 2011. Mitochondrial function in the human oocyte and embryo and their role in 1212 
developmental competence. Mitochondrion 11(5):797-813. 1213 
Van Blerkom J, Runner MN. 1984. Mitochondrial reorganization during resumption of arrested 1214 
meiosis in the mouse oocyte. The American journal of anatomy 171(3):335-355. 1215 
Van den Steen P, Rudd PM, Dwek RA, Opdenakker G. 1998. Concepts and principles of O-linked 1216 
glycosylation. Crit Rev Biochem Mol Biol 33(3):151-208. 1217 
Virkamaki A, Yki-Jarvinen H. 1999. Allosteric regulation of glycogen synthase and hexokinase by 1218 
glucosamine-6-phosphate during glucosamine-induced insulin resistance in skeletal muscle 1219 
and heart. Diabetes 48(5):1101-1107. 1220 
Vosseller K, Wells L, Hart GW. 2001. Nucleocytoplasmic O-glycosylation: O-GlcNAc and functional 1221 
proteomics. Biochimie 83(7):575-581. 1222 
Vosseller K, Wells L, Lane MD, Hart GW. 2002. Elevated nucleocytoplasmic glycosylation by O-GlcNAc 1223 
results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes. 1224 
Proceedings of the National Academy of Sciences of the United States of America 1225 
99(8):5313-5318. 1226 
Wang Q, Frolova AI, Purcell S, Adastra K, Schoeller E, Chi MM, Schedl T, Moley KH. 2010. 1227 
Mitochondrial dysfunction and apoptosis in cumulus cells of type I diabetic mice. PloS one 1228 
5(12):e15901. 1229 
Wang Q, Moley KH. 2010. Maternal diabetes and oocyte quality. Mitochondrion 10(5):403-410. 1230 
Wang Q, Ratchford AM, Chi MM, Schoeller E, Frolova A, Schedl T, Moley KH. 2009. Maternal 1231 
diabetes causes mitochondrial dysfunction and meiotic defects in murine oocytes. Mol 1232 
Endocrinol 23(10):1603-1612. 1233 
Wang Z, Gucek M, Hart GW. 2008. Cross-talk between GlcNAcylation and phosphorylation: site-1234 
specific phosphorylation dynamics in response to globally elevated O-GlcNAc. Proceedings of 1235 
the National Academy of Sciences of the United States of America 105(37):13793-13798. 1236 
Webb EC. 1992. Enzyme nomenclature 1992: recommendations of the Nomenclature Committee of 1237 
the International Union of Biochemistry and Molecular Biology on the nomenclature and 1238 
classification of enzymes. Biology IUoBaM, editor. San Diego: Academic Press. 1239 
Wells L, Gao Y, Mahoney JA, Vosseller K, Chen C, Rosen A, Hart GW. 2002. Dynamic O-glycosylation 1240 
of nuclear and cytosolic proteins: further characterization of the nucleocytoplasmic beta-N-1241 
acetylglucosaminidase, O-GlcNAcase. The Journal of biological chemistry 277(3):1755-1761. 1242 
Wells L, Vosseller K, Hart GW. 2001. Glycosylation of nucleocytoplasmic proteins: signal transduction 1243 
and O-GlcNAc. Science 291(5512):2376-2378. 1244 
Wells L, Whelan SA, Hart GW. 2003. O-GlcNAc: a regulatory post-translational modification. Biochem 1245 
Biophys Res Commun 302(3):435-441. 1246 
Whelan SA, Hart GW. 2003. Proteomic approaches to analyze the dynamic relationships between 1247 
nucleocytoplasmic protein glycosylation and phosphorylation. Circ Res 93(11):1047-1058. 1248 
Wilkinson B, Gilbert HF. 2004. Protein disulfide isomerase. Biochim Biophys Acta 1699(1-2):35-44. 1249 
Williams SA, Blache D, Martin GB, Foot R, Blackberry MA, Scaramuzzi RJ. 2001. Effect of nutritional 1250 
supplementation on quantities of glucose transporters 1 and 4 in sheep granulosa and theca 1251 
cells. Reproduction 122(6):947-956. 1252 
Wittmaack FM, Kreger DO, Blasco L, Tureck RW, Mastroianni L, Jr., Lessey BA. 1994. Effect of 1253 
follicular size on oocyte retrieval, fertilization, cleavage, and embryo quality in in vitro 1254 
fertilization cycles: a 6-year data collection. Fertil Steril 62(6):1205-1210. 1255 
Wongsrikeao P, Otoi T, Taniguchi M, Karja NW, Agung B, Nii M, Nagai T. 2006. Effects of hexoses on 1256 
in vitro oocyte maturation and embryo development in pigs. Theriogenology 65(2):332-343. 1257 
Woolford M. 2012. Exploring the function of glutamine fructose-6-phosphate transaminase (GFPT2) 1258 
in embryonic development. New South Wales: University of New South Wales. 1259 
Wyman A, Pinto AB, Sheridan R, Moley KH. 2008. One-cell zygote transfer from diabetic to 1260 
nondiabetic mouse results in congenital malformations and growth retardation in offspring. 1261 
Endocrinology 149(2):466-469. 1262 
Xu Y, Osborne BW, Stanton RC. 2005. Diabetes causes inhibition of glucose-6-phosphate 1263 
dehydrogenase via activation of PKA, which contributes to oxidative stress in rat kidney 1264 
cortex. Am J Physiol Renal Physiol 289(5):F1040-1047. 1265 
Yang X, Ongusaha PP, Miles PD, Havstad JC, Zhang F, So WV, Kudlow JE, Michell RH, Olefsky JM, Field 1266 
SJ, Evans RM. 2008. Phosphoinositide signalling links O-GlcNAc transferase to insulin 1267 
resistance. Nature 451(7181):964-969. 1268 
Yang YR, Song M, Lee H, Jeon Y, Choi EJ, Jang HJ, Moon HY, Byun HY, Kim EK, Kim DH, Lee MN, Koh A, 1269 
Ghim J, Choi JH, Lee-Kwon W, Kim KT, Ryu SH, Suh PG. 2012. O-GlcNAcase is essential for 1270 
embryonic development and maintenance of genomic stability. Aging cell 11(3):439-448. 1271 
Yang YR, Suh P-G. 2013. O-GlcNAcylation in cellular functions and human diseases. Advances in 1272 
Biological Regulation(0). 1273 
Zachara NE, Hart GW. 2004a. Nucleocytoplasmic glycosylation, O-GlcNAc: identification and site 1274 
mapping. In: Dickson R, Mendenhall M, editors. Signal Transduction Protocols, Methods in 1275 
Molecular Biology. Totowa, USA: Humana Press. pp 175-194. 1276 
Zachara NE, Hart GW. 2004b. O-GlcNAc a sensor of cellular state: the role of nucleocytoplasmic 1277 
glycosylation in modulating cellular function in response to nutrition and stress. Biochimica 1278 
et biophysica acta 1673(1-2):13-28. 1279 
Zachara NE, O'Donnell N, Cheung WD, Mercer JJ, Marth JD, Hart GW. 2004. Dynamic O-GlcNAc 1280 
modification of nucleocytoplasmic proteins in response to stress. A survival response of 1281 
mammalian cells. The Journal of biological chemistry 279(29):30133-30142. 1282 
Zhang CH, Qian WP, Qi ST, Ge ZJ, Min LJ, Zhu XL, Huang X, Liu JP, Ouyang YC, Hou Y, Schatten H, Sun 1283 
QY. 2013. Maternal diabetes causes abnormal dynamic changes of endoplasmic reticulum 1284 
during mouse oocyte maturation and early embryo development. Reprod Biol Endocrinol 1285 
11:31. 1286 
Zhang X, Wu XQ, Lu S, Guo YL, Ma X. 2006. Deficit of mitochondria-derived ATP during oxidative 1287 
stress impairs mouse MII oocyte spindles. Cell research 16(10):841-850. 1288 
Zhou J, Neidigh JL, Espinosa R, 3rd, LeBeau MM, McClain DA. 1995. Human glutamine: fructose-6-1289 
phosphate amidotransferase: characterization of mRNA and chromosomal assignment to 1290 
2p13. Hum Genet 96(1):99-101. 1291 
 1292 
 1293 
Figure 1. Glucose metabolism in cumulus-oocyte complexes (COCs) 1294 
Glucose is known to be metabolised through four pathways in the COC: the polyol 1295 
pathway, the pentose phosphate pathway, glycolysis and the hexosamine 1296 
biosynthesis pathway. UDP-N-acetylglucosamine, the end product of the 1297 
hexosamine pathway, is an important component of proteoglycans and 1298 
glycosaminoglycans, and the substrate for ß-O-linked glycosylation of a wide variety 1299 
of proteins. 1300 
 1301 
Figure 2. Immunohistochemical localisation of β-O-linked glycosylation in mouse 1302 
COCs 1303 
Mouse COCs were collection after 6 h in vitro maturation in control medium (5.55 1304 
mM glucose) ± 2.5 mM glucosamine. CTD110.6 (green) shows O-GlcNAc and DAPI 1305 
(blue) shows nuclear staining. 1306 
